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SUMMARY 
This report describes the results of the 2nd collaborative study of an HPLC method for the growth 
promoter olaquindox in two piglet feeds. The collaborative study forms part of the EU-project 
"Development and Validation of HPLC-methods for the official control of Coccidiostats and 
Antibiotics used as Feed Additives (CANFAS, SMT4-CT98-2216). 
In the first collaborative study many laboratories reported difficulties with the practicability of the 
method due to the low ratio between the volume of extraction solvent (50 ml) and the weight of 
feed (25 g). For this reason the CANFAS-method was modified in such a way that the ratio 
between the extraction volume and the sample weight was increased to 5. A second round of 
collaborative studies for final validation of the method was organised. 
The principle of the method is as follows: The sample is extracted by a mixture of water -
methanol. The content of olaquindox is determined by reversed-phase high-performance liquid 
chromatography (HPLC) with UV-detection at 380 nm. 
The samples that were tested in the collaborative study were 2 piglet feeds with declared 
olaquindox contents of 2,5 mgAg and 10 mgAg respectively. The feed samples were sent to the 
participants as blind duplicates. The participants were asked to do duplicate determinations per 
sample. 
Results were reported by 22 laboratories. Statistical evaluation was performed according to ISO 
5725. The results show that with the modified method acceptable results are obtained for 
repeatability (rsdr < 10 %) and reproducibility (Horrat ratios < 2). 
During the first collaborative study blank samples were analysed: no interfering substances were 
detected, so the results obtained for the blank feed were acceptable. 
Acceptable results were obtained for recovery, reported values ranged between 52 and 107%. 
The final method can be recommended for adoption as an official method and together with the 
results of the collaborative study it will be sent to the European Commission (CEMA), CEN and 
ISO. 
1 INTRODUCTION 
Within the framework of the EU-project "Development and Validation of HPLC-methods for the 
official control of Coccidiostats and Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-
2216), the official EC-method for olaquindox (Directive 98/64/EC) has been validated for low 
contents in feeds. Olaquindox is a growth promoter that was registered for use in feeds for 
piglets with contents ranging from 15-50 mg/kg (50 -100 mgAg for milk replacers). Since 
September 1999, the use of olaquindox as a feed additive is banned in the EU. In order to allow 
adequate control of possible illegal use, the objective was to validate the official EC-method (an 
HPLC method with UV-detection) for contents 5-10 times lower than the lowest content formerly 
permitted, viz. down to 1,5 mgAg. 
The method was validated by LUFA - Augustenberg, Karlsruhe, Germany. Compared with the 
original method, the ratio between the extraction volume and the sample weight was modified: in 
the original method this ratio was 10; in order to increase the limit of detection, in the modified 
method this ratio was decreased to 2 (see report K. Michels, Final report on evaluation of method 
validation for olaquindox and carbadox in feeds at low contents, 01-11-1999). 
Subsequently, the method was subjected to between-lab validation by the State Laboratory, 
Dublin, Ireland (see report P. Shearan, January 2000) and Istituto Superiore di Sanita (I.S.S.), 
Roma, Italy (see report G. Brambilla, January 2000). In general, the criteria as described in the 
amended Project Plan are fulfilled. The recoveries are often lower than 80 % (down to 60 %) but, 
while the use of olaquindox has been forbidden, this is not regarded as a major shortcoming (see 
Second Annual Report CANFAS, J. de Jong, 12-08-2000). 
Prior to the first collaborative study, a kick-off meeting was organised (Brussels, 13-14/6/2000) 
and participating laboratories were given the opportunity to familiarise themselves with the 
method, using feed samples with stated contents of olaquindox. Also prior to the production of 
the materials for the collaborative study, separate batches of the materials had been produced for 
homogeneity and stability testing. The between- and within-sample homogeneity was satisfactory 
and the results showed that olaquindox is stable in the feeds at room temperature during a period 
of 4 months (see Second Annual Report CANFAS, J. de Jong, 12-08-2000). 
In the first collaborative study many laboratories reported difficulties with the practicability of the 
method due to the low ratio between the volume of extraction solvent (50 ml) and the weight of 
feed (25 g). 
During the evaluation meeting organised after the first collaborative study, it was decided to 
modify the CANFAS method in such a way that the ratio between the extraction volume and the 
sample weight was increased to 5. A second round of collaborative studies for final validation of 
the method was organised. 
The samples that were prepared for the collaborative study were two piglet feeds with declared 
olaquindox contents of 2,5 and 10 mgAg respectively. The feed samples were sent to the 
participants as blind duplicates. Before these samples were shipped, the between sample 
homogeneity of the feed samples containing olaquindox was checked with satisfactory results 
(see par. 3.1.2). 
Together with the samples, a letter with instructions, reporting forms, etc. was sent to the 
participants (see Appendix 1). 
This report describes the results of the 2nd collaborative study. 
2 PARTICIPANTS 
The following laboratories/persons participated in the collaborative study. 
- Administration des Services Technique de l'Agriculture Division des Laboratoires, Ettelbruck, 
Luxemburg; C. Strottner 
- Bundesambt und Forschungszentrum für Landwirtschaft (BFL), Wien, Austria; B. Stoisser, M. 
Wieshaider 
- INETI/DTIA, Lisbon, Portugal; I. Felgueiras, C. Saldanha 
- Istituto Superiore di Sanita, Lab. Med. Veterinaria, Roma, Italy; G. Brambilla, C. Cartoni, M. 
Fiori. 
- Istituto Zooprofilattico Sperimentale della Lombardia e dellémilia Ronagna, Reparto Chimico, 
Brescia, Italy; E. Faggionato, A. Baiguera. 
- Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, Italy; C. Testa, N. Rubattu, A. 
Serra 
- Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy; G. Biancotto, B. Allegretta 
- Istituto Zooprofillatico Sperimentale delle regioni Lazio e Toscana, Roma, Italy; A. Ubaldi, A. di 
Lullo. 
- Laboratoire Inter Régional DGCCRF, Rennes, France; C. Genouel, M.C. Rues, M. Joubert. 
- Laboratório Arbitral Agroalimentario, Madrid, Spain; D.A. Pons, J. Mufioz 
- Laboratório Nacional de Sanidad y Produccion Animal - M.A.P.A., Santa Fe, Spain; R. Checa-
Moreno, A. Ariza-Avidad. 
- Laboratory of the Government Chemist, Teddington, United Kingdom; J. Cowles 
- LNIV, Lisbon, Portugal; J.M. Nunes da Costa, M.B. Casqueira. 
- LUFA - Augustenburg, Karslruhe, Germany; K. Michels, S. Witzemann. 
- LUFA-ITL Kiel, Kiel, Germany; H. Wehage, H. Graepel 
- Masterlab, Putten, The Netherlands; K. van Schalm, A. Schaaf. 
- National Veterinary Institute, Uppsala, Sweden; E. Nordkvist, A. Stepinska 
- Plant Production Inspection Centre Agricultural Chemistry Department, Vantaa, Finland; R. 
Muhonen, Y. Hyvónen 
- Rijksontledingslaboratorium, Tervuren, Belgium; K. Haustraete, A. Fontaine, M. Lekens, R. van 
Sandt s 
- RIKILT, Wageningen, The Netherlands; H. Kleijnen, H. van der Kamp 
- State Laboratory Dublin, Ireland, P. Shearan 
- Universität Hohenheim, Landesanstalt für Landwirtschaftliche Chemie, Stuttgart, Germany; K. 
Schwadorf, A. Eschle 
3 MATERIALS 
3.1 Samples for collaborative study 
3.1.1 Sample composition 
Specifications of the samples, which were produced for the collaborative study, are given in 
Table 1. 
Table 1: Specifications of the samples 
Type of feed 
Piglet feed 
Piglet feed 
Declared 
content 
2,5 
10 
Units 
mg/kg 
mgAg 
Subcontractor 
IPC - Dier, Barneveld 
(NL) 
IPC - Dier, Barneveld 
(NL) 
Date of 
production 
25-09-2001 
25-09-2001 
The complete composition of the feeds is given in Appendix 2 (in Dutch). The main composition 
of the two feeds is given in Table 2. 
Table 2: Main composition of the two feeds 
Product: Piglet feed 
Parameter 
Crude protein 
Crude fat 
Starch 
Crude fibre 
Crude ash 
Moisture 
Content (%) 
18,1 
4,3 
39,3 
4,4 
5,9 
12,3 
The composition of the feed, with regards to the ingredients, was the same as of the feeds that 
were produced by IPC-Dier in September 1999 for stability testing (see Report on homogeneity 
and stability studies of samples for the collaborative studies for olaquindox, K. Michels, LUFA 
Augustenberg, Germany, 05/05/2000) and in September 2001 for the first collaborative study 
(see report of first collaborative study see RIKILT report 2002.014). The composition of the 
feeds, in terms of crude protein, fat, etc, was nearly the same. In the produced feeds for the 
second round of collaborative study the crude ash content is somewhat higher (5,9% - 4,7%). 
The feed products have been prepared in a quantity of 500 kg each. To achieve a maximum 
degree of homogeneity halfway through the production 54 kg of feed are withdrawn from the 
stream for subsampling activities and put into three sacks of 18 kg. After discarding the top 
layer (ca. 2 kg) about 30 - 50 subsamples of approx. 250 grams have been taken (manual 
distribution with a shovel) from each of these sacks. The subsamples were stored in double 
paper sacks. 
All subsamples have been stored at room temperature (ca. 20 °C). 
3.1.2 Sample homogeneity 
The homogeneity of the samples was studied by LUFA Augustenberg by random selection of 10 
subsamples, applying the HPLC-method developed in CANFAS (see Annex 1 of Appendix 1). 
The results of the homogeneity determinations of the individual feeds are attached in Appendix 
3. Table 3 gives a summary of these results. 
Table 3: Results of homogeneity tests for olaquindox in piglet feeds 
Results 
Product 
Piglet feed 
Piglet feed 
Declared 
content 
(mgAg) 
2,5 
10 
Measured 
content 
(mgAg) 
2,90 
9,90 
Homogeneity results 
Between sample 
CV (%) 
7,5 
9,5 
Within sample CV (%) 
Not determined 
Not determined 
According to the Project Plan the CV's for homogeneity should not exceed 2 times the CV's for 
repeatability (CVhom < 2 CVr). Based on previous results of within-lab validation (see Second 
Annual Report CANFAS, J. de Jong, 12-08-2000) the maximum limit for CVhom was set to 16 %. 
Both between sample CV's fulfil these requirements. Thus, it is concluded that the samples are 
sufficiently homogeneous. 
3.1.3 Sample logistics 
The samples were sent as blind duplicates. The codes are given in Appendix 4. The samples 
were sent to the participants by courier service on 2 November 2001 together with a letter with 
instructions (Appendix 1). During transport no special precautions were taken with regards to the 
temperature of the samples. 
3.2 Reference standard 
The reference standard was supplied by Dr. A. Plöger, Danish Plant Directorate, Lyngby (DK). 
According to the specifications (see Report 2002.014 ), the purity of the reference standard (Lot 
Nr. 890416) is 99,46%. 
The expiration date of the reference standard was April 2001. The identity and content was 
checked by RIKILT. The identity could be confirmed by UV, 'H-NMR as well as mass spectrometry. 
The purity was determined by ^-NMR and UV spectroscopy and was shown to be approx. 100 % 
(see Report 2002.014). 
The participants were instructed to set the purity of the reference standard to 100 % (see 
Appendix 1). 
4 METHODS 
4.1 Method of analysis 
The method of analysis is included as annex 1 to Appendix 1. The participants were instructed 
that this method has to be used without any modifications. 
4.1.1 HPLC-conditions 
Various types of HPLC-columns were used. The following columns were recommended in the 
method: 
- Hypersil ODS 5 urn, 200 x 4,6 mm; 
- Spherisorb ODS-2 5 urn, 250x4,6 mm; 
- LUNA CI8(2) 250x4,6 mm. 
The mobile phase described in the method is a mixture of water and methanol 900:100 (v/v). 
Three laboratories used a different mobile phase. 
The HPLC conditions (Column and mobile phase) used by the participants are shown in Table 4. 
4.2 Method for statistical evaluation 
Statistical evaluation was performed according to ISO 5725 Part 2: Basic method for the 
determination of repeatability and reproducibility of a standard measurement method (First 
edition, 1994-12-15). 
The scrutinity of results for consistency and outliers was checked by 
Graphical consistency techniques: Mandel's h plot for between-laboratory variability, Mandel's k 
plot for within-laboratory variability 
Numerical outlier techniques: Cochran's test of the within-laboratory variability, Grubbs' test (single 
and double) for between-laboratory variability 
Whenever necessary and appropriate, laboratories which showed consistently high within-cell 
variation and/or extreme cell means across many levels and/or Cochran or Grubbs' outliers were 
contacted to try to ascertain the cause of the discrepant behaviour. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility of the method. The HORRAT ratios are given in Table 5. The HORRAT ratios should 
be lower than 2 (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). 
Table 4: HPLC-conditions 
Partner 
12 
15 
16 
17 
18 
20 
21 
22 
23 
24 
25 
26 
29 
31 
32 
33 
34 
35 
37 
38 
40 
41 
Column 
Tracer extrasil ODS 5x25x0,46 
Inertsil ODS-2; 5 um; 250 x2,6 mm 
Phenomenex LUNA C18 (2); 5 um; 
150x4,6 mm 
SperisorbS10 0DS-l; 10 u 
Sperisorb ODS-2; 5 um; 150 x 4,6 
mm; 
ODS Hypersil C18; 5 um; 200 x 4,6 
mm 
Supelcosil LC18; 25 cm x 4,6 mm+ 
supelguard LC18; 2 cm x 4,6 mm 
Hypersil C18 ODS BDS; 5 um; 250 x 
4,6 mm 
Not reported 
Waters C18; 5 um; 250 x 4,6 mm 
RP C18 Lichrocart; 5 um; 250 mm x 
4 mm (Merck) 
Spherisorb ODS 2; 5 um; 250 mm x 
4,6 mm 
Nova-Pak C18; 4 um; 4,6 x 250 mm 
As described in the method 
Lichrospher RP-Select B; 5 RP-Select 
B; 5 um; 250x4 mm 
As described in the method 
Not reported 
As described in the method 
Lichrosper RP18-5 endcapped ; 25 x 
4 mm 
Symetry C-18; 3,5 urn; 150 x 2,1 mm 
C18 sperical; 5 urn; 3,9 x 150 mm 
Waters 
As described in the method 
Mobile phase 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
Acetonitril: acetate buffer (0,01 M; pH 4,6) 
Gradient elution 
As described in the method 
Not reported 
As described in the method 
Phosphate buffer(0,0? M; pH 2,8): Acetonitrile 
Gradient elution 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
Not reported 
As described in the method 
As described in the method 
Isocratic methanol/water 5:95 
As described in the method 
As described in the method 
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5 RESULTS 
For each participant the reported results for the samples, the completed questionnaire and 
representative chromatograms are annexed in Appendix 5. 
5.1 Statistical evaluation 
Originally laboratory 12 reported results that were not in agreement with the results of the other 
participants and that deviated much from the theoretical olaquindox concentrations. The reported 
results from lab 12 were 0.50, 0.53, 0.53, 0.53 mg of olaquindoxAg for the sample with a 
declared content of 2.5 mgAg and 1.99, 2.04, 1.99, 2.03 mg of olaquindoxAg for the sample 
with a declared content of 10 mgAg- Due to the magnitude of the deviations it was most likely 
that the results would cause outliers on both levels. Lab 12 was contacted to try to ascertain the 
cause of the discrepant behaviour. According to the explanation this lab had met problems with 
the solubility of the reference standard, because they had prepared a stock standard solution 
more concentrated than the one indicated in the method. After repetition of the analysis by 
following exactly the procedure as described lab 12 reported new values. Based on the findings 
mentioned above it was decided to accept the new results. 
The results reported by the participants are given in Table 6. 
Statistical analysis shows that the results of the laboratories do not contain Cochran or Grubbs' 
outliers or stragglers. The values for the statistical parameters (mean, relative standard deviations 
for repeatability and reproducibility) are given in Table 6. According to the Project Plan, the rsdr-
values should be < 10 %. For both samples this criterion is met and consequently it can be 
concluded that the repeatability is satisfactory. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). The HORRAT ratios 
are given in Table 5. The HORRAT ratios should be lower than 2. For both samples this criterion is 
met and established rsdR-values are in line with values predicted by the Horwitz equation. 
Consequently it can be concluded that the reproducibility of the changed method is satisfactory. 
Table 5: Horrat ratios of the olaquindox collaborative study 
Mean 
2,47 
8,79 
Predicted 
rsdR 
14,0 
11,5 
Established 
rsdR 
18,5 
13,1 
Horrat1 
1,33 
1,13 
Conclusion 
Reproducibility OK 
Reproducibility OK 
1
 = Horrat is the ratio between the established rsdR and the predicted rsdR 
The Mandel h and k plots are shown in Figure 1. 
n 
Table 6: Results reported by the participants. 
Lab 
12 
15 
16 
17 
18 
20 
21 
22 
23 
24 
25 
26 
29 
31 
32 
33 
34 
35 
37 
38 
40 
Sample 
41 | 
number of labs 
m (mgAg) 
rsdr(%) 
rsdR (%) 
Result (mgAg) 
0LA2 
2.5 ppm 
1,90 
2,85 
2,70 
2,97 
2,10 
2,31 
3,40 
2,45 
2,43 
2,10 
2,88 
2,20 
1,66 
2,70 
3,16 
2,70 
2,40 
2,00 
2,02 
2,30 
2,67 
2,67 
0LA2 
2.5 ppm 
2,29 
2,63 
2,63 
3,03 
1,90 
2,33 
3,43 
2,55 
2,30 
2,01 
2,86 
2,19 
1,61 
3,10 
2,81 
2,60 
2,20 
2,00 
1,92 
2,36 
2,82 
2,82 
0LA2 
2.5 ppm 
1,71 
2,89 
2,60 
3,00 
2,10 
2,44 
3,35 
2,60 
2,35 
2,09 
2,88 
2,25 
1,90 
2,37 
3,14 
2,90 
1,90 
2,00 
1,87 
2,60 
2,87 
2,48 
0LA2 
2.5 ppm 
1,34 
2,92 
2,71 
2,95 
2,50 
2,38 
3,48 
2,63 
2,46 
2,01 
3,02 
2,25 
1,86 
2,57 
2,69 
2,70 
1,90 
2,00 
1,88 
2,22 
2,84 
2,60 
22 
2,47 
6,56 
18,5 
0LA2 
10 ppm 
6,88 
10,68 
9,73 
10,30 
8,60 
9,09 
9,97 
9,98 
8,55 
8,89 
10,25 
7,32 
6,49 
8,71 
8,77 
9,10 
8,60 
7,90 
7,54 
7,82 
8,84 
9,85 
0LA2 
10 ppm 
6,99 
10,41 
9,52 
10,60 
8,50 
9,10 
9,41 
9,73 
8,60 
7,99 
10,33 
7,76 
6,53 
9,09 
8,37 
8,80 
8,30 
7,50 
8,09 
6,86 
8,87 
9,93 
0LA2 
10 ppm 
6,57 
9,91 
9,65 
10,05 
9,40 
9,00 
9,80 
9,80 
9,34 
8,40 
10,50 
7,77 
5,70 
9,47 
9,05 
8,90 
8,80 
7,60 
8,34 
7,50 
8,93 
9,77 
0LA2 
10 ppm 
6,74 
9,50 
9,49 
9,97 
9,60 
8,99 
9,16 
9,88 
9,50 
8,69 
10,56 
7,85 
5,97 
9,40 
9,05 
8,80 
8,40 
7,70 
7,91 
7,83 
8,96 
9,98 
22 
8,79 
3,56 
13,1 
12 
Figure 1: Mandel h and k plots of results reported by the participants. 
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5.2 Recoveries 
Table 7: Recoveries 
Partner 
12 
15 
16 
17 
18 
20 
21 
22 
23 
24 
25 
26 
29 
31 
32 
33 
34 
35 
37 
38 
40 
41 
Spiking level (mg/kg) 
25 
50 
2,5 
3,65 
3,75 
10 
2,5 
2,5 
2,5 
3,2/6,3 
Not reported 
2,5 
2,5 
2,5 
2,5 
2,5 
2,5 
5 
Not reported 
3,1 
2,5 
2 
2,5 
2,5 
Recovery 1 in % 
95 
91 
89 
75 
98 
88 
62 
88 
98 
105 
Not reported 
83 
91 
68 
104 
88 
84 
102 
95 
106 
79 
52 
96 
101 
Recovery 2 in % 
93 
74 
72 
88 
101 
97 
Not reported 
80 
90 
107 
91 
83 
100 
76 
53 
98 
99 
Average recovery in (%) 
95 
91 
91 
75 
98 
88 
67 
88 
100 
101 
Not reported 
82 
91 
68 
106 
90 
84 
102 
95 
103 
78 
53 
97 
100 
Recoveries range from 52-107 %. This range is broader than the range (60 - 90 %) that was 
measured in the between-lab validation of the method (see Second Annual Report CANFAS, J. de 
Jong, 12-08-2000). 
Although the mean recovery value reported by lab 38 (53 %) is low, it is not a Grubbs outlier or a 
straggler. 
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5.4 Remarks 
Table 8: Remarks made by the partners 
Partner 
12 
15 
16 
17 
18 
20 
21 
22 
23 
24 
25 
Remarks 
No remarks 
No remarks 
ad 3.5.1.: Concentration of Olaquindox stock standard solution was 36,5 ug/ml; 
ad 3.5.2.: Concentration of the corresponding calibration solutions: 0,365; 0,730; 
1,825; 3,650 and 7,300 ug/ml 
ad 5.3.2.: Linear regression calculated: 0,99999 
ad 5.2: Extraction: the following parameters were used: 
- Centrifugation 10 minutes with 7000 rpm (instead of filtration step) 
- The supernatant liquids were additionally filtered by using membrane filters 
(Machery&Nagel, Chromafil Type A-45/25, 0,45 urn) 
No remarks 
HPLC equipment: pump, autosampler, column oven = HP1050; DAD = HP1100 
Slight modifications: 
- ad 3.5.1.: Stock standard solution = 50 mg, weigh to the nearest 1 mg, in 
2000 ml water. 
- ad 3.5.2.: 1,25 ug/ml standard solution = 5 ml diluted to 100 ml (instead 2,5 
ml to 50 ml) 
- Samples stored at refrigerated temperature until analysis (<8 °C). 
- Filtration and centrifugation of the extracts. 
No remarks 
We centrifuged 10 ml of the final extract instead of filtering the whole extract on a 
paper filter. Then we filtered 2 ml of the centrifuged extract on an Acrodisc filter 
(0,45 urn) before HPLC analysis. 
The Olaquindox content was calculated from the peak area by reference to the 
calibrations graph. 
Not reported 
The extraction step is improved if compared to the first edition of this method. Still, 
centrifugation is necessary as well as filtration through 0,45 urn just before HPLC 
injection. 
Column overpressure recorded after repeated injections with RT not constant. It is 
suggested to reduce flow rate to 1 ml/min with a slight increase of the organic 
phase. 
As alternative we suggest a gradient elution able to clean the column. 
15 
Partner 
26 
29 
31 
32 
33 
34 
35 
37 
38 
40 
41 
Remarks 
The procedure was well documented and straight forward to follow. 
We have had one major problem with retention time stability of olaquindox. Initial 
injections of all standards and pre-injections (to verify system stability) all gave 
excellent response, Rt was 9,9 min. The blank sample was then injected and gave a 
zero response at the Rt of olaquindox. However, after this time the Rt of olaquindox 
reduced to between 9,0 and 9,2 minutes, but the signal response did not change. 
Initially we thought that this may have been a temperature effect as we run the 
samples overnight and we know that the laboratory temperature rises when the air 
conditioning is switched off. We therefore re-extracted the samples and put the LC-
column in an oven at 35 °C and reduced the flow rate to minimise these effects. 
However, it made no difference. 
No remarks 
No remarks 
No remarks 
No remarks 
No remarks 
No remarks 
The method is now easier to manipulate using the modifications in Annex 1. 
We carried out the entire method in glass centrifuge tubes. 
i) flat bed shaker used: these tubes were put horizontal on bed - effective 
shaking/mixing noted. 
ii) after shaking the tubes were placed in centrifuge for 5 min. Therefore no need to 
use GFA filters. Extracts were filtered prior to LC. 
LC-conditions: working at high psi: 1 ml/min ~ 2800 psi 
We have used two different feed samples from our collection as blank feed for 
recovery purposes. They do not belong to the other CANFAS Collaborative feed 
samples because we spent all of them. So, one sample is lamb feed and the other 
one is a piglet feed. Both of them had got a similar aspect to the CANFAS 
Collaborative II feed samples. We have observed that recovery and blank samples 
make spherical clusters (lump) after addition of olaquindox standard solution in 
water. These lumps were not broken after addition of methanol. 
No remarks 
No remarks 
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6 CONCLUSIONS 
From the results it can be concluded that with the modified method acceptable results are 
obtained for repeatability (rsdr < 10 %) and reproducibility (Horrat ratios < 2). 
During the first collaborative study blank samples were analysed: no interfering substances were 
detected, so the results obtained for the blank feed were acceptable. 
Reported values for recovery ranged between 52 and 107%. The recoveries are sometimes lower 
than 80 % (down to 52 %) but, while the use of olaquindox has been forbidden, this is not 
regarded as a major shortcoming (see Second Annual Report CANFAS, J. de Jong, 12-08-2000). 
The remarks made by the participants indicate that no difficulties were encountered. Some 
laboratories applied centrifugation of the samples instead of filtration. According to the method 
description this alternative may be applied. 
The final method can be recommended for adoption as an official method and together with the 
results of the collaborative study it will be sent to the European Commission (CEMA), CEN and 
ISO. 
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APPENDIX 1 
Letter with instructions, sent with the samples (with four annexes) 
Participants CANFAS collaborative study Olaquindox 
Dear colleague, 
As agreed at the CANFAS evaluation meeting June 19th, 2001 at Tervuren a second 
round of collaborative study for olaquindox has to be organised. We appreciate your 
willingness to participate very much. Together with this letter you will find: 
• 2 feed samples labeled with the text "additive: OLAQUINDOX" and with a sample 
code. The samples contain olaquindox in the range between 1 and 15 mgAg. 
• the modified method of analysis (annex 1). By participation you agree with 
application of this method! 
• the reporting form (annex 2). This form will also be send to you by E-mail as an 
Excel 5.0 file. We strongly prefer to get the results back in electronic form by E-
mail; you are asked to use the e-mail address mentioned in the right margin of this 
letter. 
• instructions for handling (milling, storage) of the samples (annex 3). 
• a questionnaire (annex 4). We kindly ask you to give us information about the 
experimental conditions, recoveries, etc.. On this form you can also give your 
remarks about the method. 
The samples must be analysed in duplicate. 
For recovery purposes we ask you to select a blank piglet feed from your own collection. 
The reference standard of olaquindox that has to be used (980416) was already sent to 
you with our letter of 31 May 2000. In the calculations this reference standard can be 
regardedas 100% pure. 
The deadline for reporting the results is December 14, 2001. 
We wish you and your colleagues the best with the collaborative study. If you have any 
questions, do not hesitate to contact us. 
Kind regards, 
DATE 
2 Novambar 2001 
SUBJECT 
CANFAS collaborative study 
olaquindox ( 71316.24) 
ENCLOSURE!!) 
4 
OUA REFERENCE 
01/0026880 
HANDLED Br 
Ing. J.J.M. Driastan 
DIRECT ITELEPHONEI LINE 
+31 317 47 55 74 
EMAIL 
j.j.m.driest anOrikilt.wag-ur.nl 
RIKILT 
Stata Institut« for Quality 
Control of Agricultural 
Products 
P.O.Box 230 
6700 AB Waganingan 
Tha Natharlandi 
VIStTORS' ADDRESS 
Building no. 123 
Bormastaag 45 
6708 PD Waganingan 
TELEfHONE S 
+31 317 47 54 00 
FA« 
+31 317 41 77 17 
CHAMBER OF COMMERCE REGISTRATION NO. 
09098104 ta Arnham 
THE INTERNET 
«rww.rikilt.waganingan-ur.nl 
dr. Jacob de Jong 
CANFAS co-ordinator 
ing. J.J.M. Driessen 
co-ordinator CANFAS collaborative 
studies 
cc. mrs. D. Bennink, European Commission, DG Research, CII/3, Brussels 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 1 - Modified method of analysis. 
Determination of low level contents of Olaquindox in Feedingstuffs 
1. Purpose and scope 
The method is for the determination of olaquindox in feedingstuffs. The limit of 
determination (=quantification) is 1,5 mg/kg. The limit of detection (=qualification) is 
0,1 mg/kg 
2. Principle 
The sample is extracted by a water methanol mixture. The content of olaquindox is 
determined by reversed-phase high-performance liquid chromatography (HPLC) 
using an UV detector. 
3. Reagents 
3.1. Methanol 
3.2. Methanol, HPLC grade 
3.3 Water, HPLC grade 
3.4. Mobile phase for HPLC 
Water (3.3)-methanol (3.2) mixture, 900+100 (V + V) 
3.5. Standard substance: pure olaquindox 2-[N-2'-(hydroxyethyl)carbamoyl]-3-
methylquinoxaline-N1 ,N4-dioxide, E 851 
3.5.1. Olaquindox stock standard solution, 25 ug/ml 
Weigh to the nearest 0,1 mg 5 mg of olaquindox (3.5) in a 200 ml graduated flask and 
add ca. 190 ml water. Then place the flask for 10 min in a ultrasonic bath (4.1). After 
ultrasonic treatment, bring the solution to room temperature, make up to the mark 
with water and mix. Wrap the flask with aluminium foil and store in a refrigerator. At 
this temperature of < 4°C the solution is stable for 1 month. 
3.5.2. Calibration solutions 
Into a series of 50 ml graduated flasks transfer 0.5, 1.0, 2.5, 5.0 and 10.0 ml of the 
standard stock solution (3.5.1). Make up to the mark with water (3.3) and mix. These 
solutions correspond to 0.25, 0.5, 1.25, 2.5 and 5.0 ug of olaquindox per ml 
respectively. 
These solutions must be prepared fresh each day. 
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4. Apparatus 
4.1. Ultrasonic bath 
4.2. Mechanical shaker 
4.3. Membrane filter, 0.45 urn 
4.4. HPLC equipment with variable wavelength ultraviolet detector 
4.4.1. Liquid chromatographic column, 250 mmx4mm, C 18, 5 urn packing, or equivalent. 
See remark 7.2. 
5. Procedure 
Note: Olaquindox is light sensitive. Cany out all procedures under subdued light or 
use amber glass ware. 
5.1. General 
5.1.1. Blank feed 
For the perfomance of the recovery test (5.1.2) a blank feed should be analysed to 
check that neither olaquindox nor interfering substances are present. The blank feed 
should be similar in type to that of the sample and on analysis olaquindox or 
interfering substances should not be detected. 
5.1.2. Recovery test 
A recovery test should be carried out by analysing the blank feed which has been 
fortified by addition of a quantity of olaquindox, similar to that present in the sample. 
To fortify at a level of 2.5 mg/kg, transfer 1 ml of the stock standard solution (3.5.1) to 
a 250 ml conical flask, add 10 g of the blank feed, mix thoroughly and leave for 10 
min mixing again several times before proceeding with the extraction step (5.2). In 
stead of 40 ml water, 39 ml water should be added in the extraction step. 
Alternatively, if a blank feed similar in type to that of the sample is not available (see 
5.1.1), a recovery test can be performed by means of the standard addition method. s 
In this case, prepare two independent laboratory sample aliquots ( A and B) of the 
feed to be examined. Spike one of them (A), before extraction with a quantity of 
olaquindox, similar to that already present in the sample. Both samples are analysed. 
Calculate the analyte content in sample A and B and calculate the recovery by 
subtraction. 
5.2. Extraction 
Weigh to the nearest 0.01 g, approximately 10 g of the sample. Transfer to a 250 ml 
conical flask, add 10 ml of methanol (3.1) and place the flask for 5 min in the ultra-
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sonic bath (4.1). Add 40 ml water and leave in the ultrasonic bath for further 15 min. 
Remove the flask from the ultrasonic bath, shake it for 30 min on the shaker (4.2) and 
filter through a folded filter or a glass fibre filter (GFA, Whatman) (see remark 7.1). It 
is highly recommended to filter the clear samples by using a membrane filter (4.3) 
additionally. Proceed to the HPLC determination (5.3). 
5.3. HPLC determination 
5.3.1. Parameters: 
The following conditions are offered for guidance, other conditions may be used 
provided that they give equivalent results. 
Analytical column (4.4.1). See remark 7.2. 
Mobile Phase (3.4): water (3.3) - methanol (3.1.) mixture, 900 + 100 (V+ V) 
Flow rate: 1.5-2 ml/min 
Detection wavelength: 380 nm 
Injection volume: 50 ul -100 ul 
Check the stability of the chromatographic system, injecting several times the 
calibration solution (3.5.3) containing 1.25 ug/ml, until constant peak heights and 
retention times are achieved. 
5.3.2. Calibration graph 
Inject each calibration solution (3.5.3) several times and determine the mean peak 
heights (areas) for each concentration. Plot a calibration graph using the mean peak 
heights (areas) of the calibration solutions as the ordinates and the corresponding 
concentrations in pglml as the abscissae. 
5.3.3. Sample solution 
Inject the sample extract (5.2) and determine the peak height (area) of the olaquindox 
peaks. 
6. Calculation of the results 
From the height (area) of the olaquindox peaks of the sample solution determine the 
concentration of the sample solution in ug/ml by reference to the calibration graph 
(5.3.2). 
The olaquindox content w (mg/kg) of the sample is given by the following formular: 
c*50 
w = 
m 
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in which: 
c = olaquindox concentration of the sample extract (5.2) in ug/ml 
m = mass of the test portion in g 
7 Remarks 
7.1 Instead of filtration through a folded filter a centrifugation step could be carried out. If 
plastic vials are used for centrifugation, a recovery study should be carried out to 
validate this application. 
7.2 The following columns could be recommended: Hypersil ODS 5 urn 200 x 4.6 mm, 
Spherisorb ODS 2 5 um 250 x 4.6 mm, LUNA C18(2) 5 urn 250 x 4.6 mm. 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: [ 
Analyte: 
J e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
Result 1 
(mg/kg) 
Result 2 
(mg/kg) 
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ADDITIVE: OLAQUINDOX 
Annex 3 - Instructions for handling of the samples 
1. Storage 
Store the samples at room temperature until analysis. Protect the material from direct light. 
2. Milling 
Grind the feed samples with a mill equipped with a 1 mm screen 
3. Mixing of the test samples before weighing 
Mix the entire sample thoroughly 
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ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: 
Chromatographic conditions: 
• Column: 
• G As described in the method 
• a Other: 
• Mobile phase: 
• D As described in the method 
• D Other: 
• Flow-rate: ml/min 
• Injection volume: ul 
• Retention time of olaquindox: min 
Chromatograms: Please include representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: % 
• Single / duplicate determinations: D single D duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mgAg 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001. 
ADDITIVE: OLAQUINDOX 
Remarks /Comments (if necessary, continue on another page) ; 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. J.J.M. Driessen 
RIKILT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax+31-317417717 
Thank you for your co-operation ! 
APPENDIX 2 
Composition of the feed samples 
BESTMIX - Afdruk mengopdracht - 2^7o9/01 - IPC DIER BARNEVELD 
250.00 Biggen opfok korrel 
biggenvoer van 12 tot 25/30 kg 
•>m 
Grondstof 
Weegschaal DW 1 
113 Zonbl.schr.2 90re 
460 Tapioca65%zetroeel 
77 Soja 45/46(arg/braz) 
Weegschaal DW 2 
145 Tarwe 
14 Gerst 
40 Mais 
(voer) 
Silo % Gewicht Tol. Cumul Gew. 
kg +/-Afw. kg 
2) 2.00 
4) 7.50 
9) 13.00 
0.30 
1.13 
1.95 
10.00 
47.50 
112.50 
( 9) 
( I D 
( 12) 
ïo.oo IH 
3 7 . 1 0 l a | 
12.00 IM 
ï f | 1-50 
ï f l 5'57 § # 1.80 
5 0 . 0 0 
2 3 5 . 5 0 
2 9 5 . 5 0 
Charge Charge 
1/ 
.1/ 
Bijstort SP4 
34 Lynzaad 
105 Vismeel 65.9% re 
0) 5.00 
0) 4.40 
Bijstort SP6 
476 Powerfood Twil melkv ( 0) 4.00 
Bijstort SP7 
21 Fumaarzuur 
78 L-lysine HCl 
79 DL-Methio-nine 
117 Krijt/kalksteen 
22 8 Monocal België 
485 Zout 
508 Prem biggen Rikilt 
Vloeistoffen 
474 Melasse riet >450s 
0) 
0) 
0) 
0) 
0) 
0) 
0) 
0 
0 
0 
0 
0 
0 
1 
. 2 5 
. 1 7 
03 
4 5 
50 
10 
00 
0.75 
0.66 
0.60 
0 
0, 
0. 
0. 
0. 
0. 
0. 
01 
01 
00 
02 
03 
01 
05 
( 3) 2.50 12.50 0.38 
Totaal : 
25.00 
47.00 
20.00 
25 
10 
25 
50 
00 
50 
12.50 
12.50 
500.00 
V. 
V. 
x/ 
'i/' 
*/ 
. . i X . . 
. . < / . . . 
. 1 / . . . 
. l / . . . 
.s... . 
.l/,. . 
. . < / . . 
( / 
s « / 
t^ 
. ( / . . 
• 
. ( / , 
l/ V 
RETOURPRODUKT 
INSTELLINGEN 
juo( fô% 
grof 4f?0P . • So. . % 
" mm ? &f>l~) 
T.R. 
V.Z. 
Z.F. 
H.M. 
L.M. 
M.D. 
[hojsçf/laag toeren 
kringloop : jajGeé5 
voormengen .00. sec 
namengen «3 9.°. sec 
. .?S~. . l/h 
Meel temp 
Matrijs diam. 
K.P. 
Laagdikte Ko 
Zeef Ko 
Kruimelen 
.S.o. °c /couieJi pt?*C 
c, S x 3 S", mm 
3o. . Amp 
.A S" cm 
mm 
Ha/Cie 
C^heit/ocA^if-e^uMc J2, 0 % 
/ î . -J.-/ , - _ L.fL. 
BESTMIX - Afdruk kostenformulier 
2 250.00 Biggen opfok korrel 
biggenvoer van 12 tot 25/30 kg 
25/09/01 - IPC DIER BARNEVELD 
Nr Grondstofnaam Aandeel Gewicht 
14 Gerst 
77 Soja 45/46(arg/braz) 
40 Mais 
145 Tarwe (voer) 
460 Tapioca65%zetmeel 
34 Lynzaad 
105 Vismeel 65.9% re 
476 Powerfood Twil melkv 
474 Melasse riet >450s 
113 Zonbl.schr.290re 
508 Prem biggen Rikilt 
228 Monocal België 
117 Krijt/kalksteen 
21 Fumaarzuur 
78 L-lysine HCl 
4 85 Zout 
79 DL-Methio-nine 
37 
13 
12 
10 
7 
5 
4 
4, 
2, 
2. 
1". 
0. 
0. 
0. 
0. 
0. 
0. 
.10000 
.00000 
.00000 
.00000 
.50000 
.00000 
.40000 
.00000 
.50000 
.00000 
00000 
,50000 
.45000 
.25000 
17000 
10000 
03000 
185 
65 
60 
50 
37 
25 
22 
20 
12. 
10, 
5. 
2. 
2. 
1. 
0. 
0. 
0. 
.500 
.000 
.000 
.000 
.500 
.000 
.000 
.000 
.500 
.000 
.000 
.500 
,250 
,250 
850 
500 
150 
Totaal 100.00000 500.000kg 
Berekend * Verschil * Nr Nutrient Minimum 
180.00 
1.00 
420.00 
7.00 
1.00 
Maximum * 
1 Re 
2 Rvet 
3 Re 
4 Vocht 
5 Ras 
6 Zetmeel 
8 Ca 
9 P 
11 Lysine 
12 Methion 
13 Meth+cys 
14 Trypt. 
15 Threon. 
16 Isoleuc 
19 Linolz. 
30 EW*100 
32 P-vert 
34 dvLys v 
3 5 dvmet 
36 dvM+C 
37 dvtryp v 
38 dvtreo v 
50 Cu 
51 Na 
53 K 
54 Cl 
59 Gewicht 
100 vit. A 
101 vit.D3 
102 vit.E 
103 BHA/ethy 
106 ethopab 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
181.11 
42.70 
43.83 
123.47 
58.90 
393.49 
7.76 
6.36 
11.37 
3.84 
6.97 
2.21 
6.81 
6.78 
10.07 
106.96 
3.58 
9.53 
3.19 
5.41 
1.72 
5.01 
73.96 
1.78 
8.74 
3.98 
100.00 
4000.00 
800.00 
734.68 
0.02 
13.00 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
mg 
g 
g 
g 
i.e. 
i.e. 
mg 
mg 
mg 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
-26.51 
•0.04 
-0.09 
10.00 
107.00 
00 
00 
00 
40 
70 
10 
1.50 
1.50 
100.00 
200.00 
65.00 
45.00 
130.00 
9.00 
107.00 
3 .00 * 
12.00 * 
* 
100.00 * 
APPENDIX 3 
Homogeneity of samples 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
,nd Homogeneity test 2 collaborative study 
Additive : 
Product : 
Olaquindox 
Piglet feed, 10 ppm 
Date of determination : 
Sample 
345312 
345314 
345327 
345328 
345344 
345345 
345363 
345372 
345393 
345425 
October 29th, 2001 
Content 
ppm 
10,5 
10,2 
10,6 
10,3 
8,7 
8,7 
8,3 
10,5 
10,9 
10,4 
Homogeneity 
Crtiterion : CVbetween = < 15% 
Average (ppm) 
SD (between samples) 
CV (between samples) 
Grubb's test, single lower 
Grubb's test, single upper 
Grubb's test, double lower 
Grubb's test, double upper 
OK 
9,90 
0,940 
9,5 
1,696 
1,016 
0,5574 
0,5574 
s 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
CAN FAS 
r — — — ——— 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Homogeneity test 2nd collaborative study 
Additive : 
Product : 
Olaquindox 
Piglet feed, 2.5 ppm 
Date of determination : 
Sample 
345301 
345318 
345323 
345334 
345339 
345371 
345392 
346402 
345412 
345432 
October 29th, 2001 
Content 
ppm 
2,7 
2,7 
2,8 
3,2 
3,1 
3,1 
2,6 
3,2 
2,9 
2,9 
Homogeneity 
Crtiterion : C V ^ ^ = < 15% 
Average (ppm) 
SD (between samples) 
CV (between samples) 
Grubb's test, single lower 
Grubb's test, single upper 
Grubb's test, double lower 
Grubb's test, double upper 
OK 
2,90 
0,219 
7,5 
1,372 
1,372 
0,5574 
0,5574 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
APPENDIX 4 
Sample codes 
Sample codes supplied to the participants in the olaquindox collaborative study, 2nd round 
OLAQUINDOX 
number of participants 22 
Participant code 
12 
15 
16 
17 
18 
20 
21 
22 
23 
24 
25 
26 
29 
31 
32 
33 
34 
35 
37 
38 
40 
41 
OLA2 piglet 
2.5 ppm 
OLA1a 
125397 
155332 
165403 
175313 
185350 
205377 
215341 
225373 
235310 
245326 
255349 
265404 
295354 
315414 
325364 
335304 
345366 
355317 
375311 
385355 
405315 
415320 
OLA2 piglet 
2.5 ppm 
OLA1b 
125419 
155407 
165423 
175431 
185353 
205428 
215401 
225416 
235325 
245410 
255383 
265413 
295356 
315429 
325409 
335347 
345386 
355322 
375387 
385369 
405391 
415330 
OLA2 piglet 
10 ppm 
OLA 2a 
125309 
155316 
165427 
175331 
185368 
205367 
215351 
225361 
235342 
245307 
255306 
265390 
295319 
315359 
325305 
335308 
345321 
355357 
375343 
385336 
405381 
415396 
OLA2 piglet 
10 ppm 
OLA 2b 
125421 
155400 
165389 
175352 
185395 
205417 
215422 
225424 
235365 
245426 
255411 
265398 
295418 
315399 
325375 
335362 
345379 
355406 
375405 
385374 
405385 
415430 
APPENDIX 5 
Table with results, questionnaire (page 1) and chromatograms 
of partner 12 
CAN FAS 
! Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 14-01-2002""! 
Analyte: 
e-mail: 
fax: 
telephone: 
[ OLAQUINDOX 
Unit 
Sample code 
125309 
125397 
125419 
125421 
Result 1 
(mg/kg) 
6,88 
1,90 
1,71 
6,57 
Result 2 
(mg/kg) 
6,99 
2,29 
1,34 
6,74 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Date (s) of analysis: 21-dec-01 
Chromatoarafic conditions: 
Column: 
1- As described in the method: 
2- Other: Tracer extrasil ODS 5x25x0,46 
Mobil phase 
1- As described in the method: yes 
2- Other: 
Flow rate: 1,3 mlxmin"1 
Injection volume: 150 ul 
Retention time of olaquindox: 9,7 min. 
Cromatograms: |ln the file word annex! 
Recovery results: 
1-Percentaje recovery: 94,7% and 91,4% 
2- Single / duplicate determinations: no 
3- If duplicte, please give bth percentages: 
4- Spiking level: 25 and 50 ug 
mAU" 
»-
6 -
4 -
2 -
- 2 -
• 4 -
DADI A, Si(-}«0.4 Hef-
i ' ' i 
-SOO.10 <PLAQDX\HH01 
1 
f 
i j \ 
10 mM. 
Externall Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
{Signal 
31/15/02 8:07:47 AM 
31.0000 
31.0000 
Signal 1: DADI A, Sig-380,4 Rief-500,80 
RetTime Type 
[min] 
Area 
[mAU*s] 
Amfit/Area Amount 
[ug/mlj Grp Name 
I--I 
9.752 PB 189.33951 1.7y5131e-3 3.31593e-l 
Totals : 3.31593e-l 
Results obtained with enhancced integrator! 
**** End of Report *** 
Olaquindox 
Instrument l 1/15/02 I P?age 1 of l 
Externall Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
D i l u t i o n 
.'Signal 
: i / 1 5 / 0 2 8:07:47 AM 
il.OOOO 
.1 .0000 
S i g n a l 1: DAD1 A, S i g » 3 8 0 , 4 Rief=500,80 
RetTime Type 
[min] 
Area 
[mAU*s] 
Amit/Area 
I 
Amount 
tug/ml] 
6rp Name 
9.577 PB 197.40469 1.7'5131e-3 3.45718e-l 
Totais : 3.45718e-l 
Results obtained with enhanc:ed integrator! 
***•• End of Report *** 
Olaquindox 
Instrument 1 1 /15 /02 8 :58:22 Ai P/age l o f l 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY - 2nd round 
|30,11,2001 | 
Je-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
155316 
155332 
155400 
155407 
Result 1 
(mg/kg) 
10.68 
2,85 
9,91 
2,89 
Result 2 
(mg/kg) 
10,41 
2,63 
9,50 
2,92 
15 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
• > * • • 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory:.. 
Contact person:. -
Oate(s) of analysis: 
Shromafograpnic confluions: 
• Column: 
• • As described in the method 
• fe Other: „3tWÄ<?:T.i.^.l!r...0Ä??.*Sf $/^..%$$.9..W!W.,X.'eA.!nt!'.. 
• Mobile phase: 
• XAs described in the method 
'" • a Other: '• 
• Flow-rate: ...A:&. m|/rnin 
• Injection volume: ..<&?....ul 
• Retention time of olaauindox:..'M... min 
Ch|,qmataBrPw'e? P l e a g e »nflWH r f P r »« f t f t f a t i w chromatopramg of: 
• Blind positive feed samples 
" Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Ptease indicate the olaquindox peak with an arrow 
Bscoverv rwiiftv 
• Percentage recovery: % 
• Single/duplicate determinations: a single X'dupiicate 
• If duplicate, please give both percentagesm$. % and ^2(c/c—> 
• Spiking level: .*.•!?.... mgAE 
DAD1 A, Siga380.4Ref=450,6û(MANNOV01\OLAQ1010.D) 
AU J 
10 
«H 
2H 
ë 
î 
V X 
- î — i i i î — i — i »~ 
sample 
-2SL _LS_ 10 12.6 
n 1 1 — 
15 
External Standard Report 
I By Signal 
Data Modified : Monday, December 03,2001 10:07:00 AM 
lier 1.0000 
n 5.0000 
1: DAD1 A. Sig=3S0.4 Ref=450,50 
ie Type Area Amt/Area Amount Grp Name 
[mAU*s] [ng/ul] 
_ | , 1 ,_, 
5BB 68.08050 2.81140e-2 9.01049 olaquindox 
9.91049 
s obtained with enhanced integrator! 
••* End of Report*** 
— i — 
17.S 
112/3/01 10:19:44 AM adl 
SQmpiC iS'SHö^ 
IS' 
DADÎ A, 618=380,4 Rflf=450,50 
External Standard Report 
" By SignaJ 
Data Modified : Monday, December 03,2001 10:07:00 AM 
>l!er 1.0000 
3ri 5.0000 
1 11: DAD1 A, 8ig=380,4 Ref=450,50 
m
* Typ* Area Amt/Area Amount Grp Name 
[mAU*s] [no/ul] 
&BB 20.10433 2.87603e-2 2.89103 olaquindox 
J
 : 2.89103 
J» obtained with enhanced Integratorl 
• - E n d of Report*** 
rt
 112/3/01 10:21:05 AM adl Pegel of 1 
u w c tyui c&i»: 
DAD1 A, SiH»380,4 Ref-450,50 
AU 
10-
2H 
0 ; J l 
"i i i i i i i • i i 
2,5 S 7.S 
—r~ 
10 
i 
12.6 
I 
16 JSC 
External Standard Report 
d By Signal 
. Data Modified : Monday, December 03,2001 10:07:00 AM 
slier 1.0000 
on 5.0000 
il 1: DAD1 A. Sig=380,4 Ref=450,50 
me Type Area Amt/Area Amount Grp Name 
| [mAU-s] [ng/ul] 
.|—| 1 1 H 
10 oiaquindox 
e : 0.00000 
jits obtained with enhanced integrator! 
imings or Errors : 
ting : Calibrated compound(s) not found 
nt 112/3/01 1022:09 AM adl Pagel of 2 
l S 
DAD1 A, Sfg=aau,*ner=«i©w,«fci 
External Standard Report 
i
 ^y Signal 
,
D
»*» Modified : Monday, December 03,2001 10:07:00 AM 
' w 1.0000 
*° 5.0000 
11:0AD1 A, Sig=38Q,4 Ref=450,50 
fle
 "type Area Ami/Area Amount Grp Name 
{mAU*s] [ng/ul] 
6 BB 16.21S3S2.86401e-2 2.32248 olaquindox 
2.32248 
J» obtained with enhanced fntegrawri 
•"End of Report*** 
2> 
^cl*» 3e.8/r 
n2A3/0l1Q;23;42AMadl Paget of 1 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
I Development and Validation of HPLC-methods for the official control of 
jCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |Nov. 20/21,2001 
Analyte: | 
Je-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
165389 
165403 
165423 
165427 
Result 1 
(mg/kg) 
9,73 
2.70 
2,60 
9,65 
Result 2 
(mg/kg) 
9,52 
2,63 
2,71 
9,49 
10 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: November 20./21., 2001 
Chromatographie conditions: 
• Column: 
• n As described in the method 
• x Other: Phenomenex LUNA C18(2), 5 urn, 150 x 4.6 mm 
• Mobile phase: 
• x As described in the method 
• D Other 
• Flow-rate: 1.3ml/min 
• Injection volume: 20 M' 
• Retention time of olaquindox: 6.9 min 
Chromatoqrams: Please include representative chromatoqrams of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: 74.7 % 
• Single / duplicate determinations: o single x duplicate 
• If duplicate, please give both percentages: 75.3 and 74.0 % 
• Spiking level: 3.65 mg/kg 
Cf\NPA) -6t^J^U>c 
*BU>4. loUkvU. f«&t r**y&. ^ 
CH . 1 C .S 5.08 ATT 1 OFFS 18 11/20/01 03:03 1 ^ * i " ,n; 
S _ 
2 .85 
3 .88 
^ 8 .43 
===- 7 . 3 5 OlwjvJ^U^ 
INJ NO. OF STD : 1 / 1 REP , 1 s t l e v e l 
D - 2 5 0 0 1 1 / 2 0 / 0 1 8 3 : 0 3 
F I L E : 3 CALC-METHOD: EXT-STD TABLE: 9 CONC: HEIGHT 
NO . RT 
4 7 .35 
AREA HEIGHT UG/I1L NAME 
6477 356 0 .730 OLA 
CH . 1 C S 5.00 ATT 1 OFFS 10 11/20/01 83:14 ^'^A'v/wJL 
= = = = = = = = = = = = = = = ^ ^ 1 .28 
2 .89 
? .36 O U ^ : ^ U A . 
D-2500 1 1 / 2 0 / 0 1 0 3 : 1 4 
F I L E : 3 CALC-METHOD: EXT-STD TABLE: 9 CONC: HEIGHT 
NO . RT 
1 1 .28 
3 7 .36 
TOTAL 
AREA HEIGHT UG/NL NAME 
11894 1321 0.001 
9437 550 1.128 OLA 
O * T T 4 
CH. 1 C . S 5 . 0 9 ATT 1 OFFS 10 l l / ' 2 0 / ' 0 1 0 2 : 2 9 i l l ic i t . to(*v*L Çe><l ïciwpl *rf'JL 
I „7ft. 
3 .58 
S .P '400 
lb 
OL*±^\j,rJu>n. 
D - 2 5 0 0 l l / ' 2 0 / ' 0 1 0 2 : 2 9 
F I L E : 3 CALC-WETHOD: EXT-STD TABLE: CONC: HEIGHT 
NO. RT 
1 1 .28 
2 3 .58 
TOTAL 
pEAK REJ s 
SF . 
SflMP-fiNT . 
1 
1 
AREA 
101796 
20992 
122788 
100 
.008 
.000 
HEIGHT 
5552 
263 
5815 
UG/'IIL 
0 .006 
0 .008 
0 .006 
NAME 
INJ NO. OF STD : 1 / 1 REP , 1st level 
D-2500 11/-21/01 18:22 
FILE: 3 CRLC-METHOD: EXT-STD TABLE: 
NO . 
5 
8 CONC: AREA 
RT 
6 . 9 2 
AREA HEIGHT UG/ML NAME 
2 1 6 8 3 1380 0 . 7 3 0 OLf lQUI 
S A ^ I C C»^ /\t$W 
CH . 1 C .S 5 . 0 0 ATT 3 OFFS 10 11/ '21/ '01 1 8 : 3 3 
8 .49 
6 .90 OU^VJUx, 
D-2500 11/21/-01 18:33 
FILE: 3 CALC-METHOD: EXT-STD TABLE: 8 CONC: AREA 
NO . 
1 
2 
3 
4 
5 
6 
7 
RT 
1 .16 
1 .84 
3 .10 
3 .44 
3 .90 
4 .52 
fi . q n 
AREA 
466313 
5756 
1303 
1792 
1525 
695 
57303 
HEIGHT 
35283 
763 
34 
119 
64 
56 
3?=M t 
UG/ML 
0 .466 
0 .006 
0 .001 
0 .002 
0 .002 
0 .001 
NAME 
O "><a o i a n t i 
u
« • i. u .Ü s . « » H M <i ur-r-b i ö n / z i / u i i v : i 8 *"**J^VN«C«)C- j r *t-4«. . 
1 1 1 
1 8 - J - * * 
— 6 . 8 8 O U ^ « ! ^ 
8 .51 
*NJ NO. OF STD : 1 / 1 REP , 1st level 
D-2500 11/21/01 17:18 
FILE: 3 CflLC-METHOD: EXT-STD TABLE: 8 CONC: AREA 
NO. RT 
5 6 . 8 8 
flREfl HEIGHT UG/ML NAME 
2 1 6 6 2 1 4 5 5 0 . 7 3 0 OLflQUI 
C H
• 1 C.S 5 . 0 0 ATT 3 OFFS 10 1 1 / 2 1 / 0 1 1 7 : 2 9 
S*i«l»tt tt,A*_ AtSWZ 
8 .43 
1 . 8 4 i i a 
6 .8 5 ÖU^viUJLöX. 
D
~ 2 5 0 0 1 1 / 2 1 / 0 1 1 7 : 2 9 
F I L E : 3 CflLC-nETHOD: EXT-STD TABLE: 8 CONC: flREfl 
NO . 
1 
2 
3 
4 
5 
6 
7 
8 
RT 
1 .16 
1 . 84 
3 . 8 4 
3 . 42 
3 . 9 3 
4 . 4 5 
6 . 8 5 
Q A-r 
flREfl 
454728 
5 4 1 6 
2285 
1 5 0 2 
1568 
488 
1 5 8 4 3 
£ 0 1 7 
HEIGHT 
3 4 0 3 5 
7 2 2 
6 4 
1 0 3 
94 
42 
971 
3 1 3 
UG/ML 
0 . 4 5 5 
0 . 0 0 5 
0 . 0 0 2 
0 . 0 0 2 
O . 0 0 2 
0 . 0 0 0 
0 . 5 3 4 
0 . 0 0 7 
NAME 
OLflQUI 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
]Development and Validation of HPLC-methods for the official control of 
ICoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |9.+10.01.2002 | 
Analyte: [ 
|e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
175313 
175331 
175352 
175431 
Result 1 
(mg/kg) 
2,97 
10,30 
10,05 
3,00 
Result 2 
(mg/kg) 
3,03 
10,60 
9,97 
2,95 
I l 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2 0 0 1 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
. /i i 
Laboratory: .& 
Contact person:.. 
Date(s) «*^.AMJMJ.<#L 
Chromatnpraphir: conditions: 
• Column: 
• D As described in the method 
. o Öfter: .JfktU.M.b. U.S. QPj-J fa 
• Mobile phase: 
• X"As described in the method 
• D Other: 
• Flowate: ../l.iQ. ml/min 
• Injection volume: .vlQ. pi 
• Retention time of olaquindox: fcxfi.. min 
Chromatograms; Please Inf tM« representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
Becoverv results: 
Percentage recovery: .VS.. % 
Single/duplicate determinations.-ysingle o duplicate 
If duplicate, please give both percentages: % and % 
Spiking level: .?.'.7.rT. mgAg 
o 7efceu4o.qe recovery : $i A 
D-7000 HSM: Olaquindox Series: 0226 
Sample Name: 175313 
Analyzed: 09.01.02 13:58 
Data Path: C:\Win32App\HSM\OLAQU\DATA\0226\ 
Application: Olaquindox 
Injection from this vial: 1 of 1 
Sample Description: 
Reported: 15.01.02 10:13 
Processed: 15.01.02 10:13 
Series:0226 
Vial Number: 6 
Volume: 20,0 ul 
Chrom Type: Fixed WL Chromatogram, 380 nm 
% 
4J 
C 
i i i l | l i i i i i i i i | i l l i j i i i V | i i i i I i l l i | i i i i I i i ' i | i i i i I i i i i | i i i i i i i i i | i i i i 
Retention Time (min) 
Acquisition Method: Olaquindox 
Column Type: RP 18 
Pump A Type: L-7100 
Solvent A: MeOH/H20 
Solvent C: MeOH/H20 
Peak Quantitation: AREA 
Calculation Method: EXT-STD 
Solvent B: MeOH/H20 
Solvent D: MeOH/H20 
Sample Amount: 0,200 
Scale Factor 1: 1,000 
Name 
Olaqu 
RT 
4,28 
6,89 
Area 
431 
7772 
8203 
Cone 1 
0,000 
2,973 
2,973 s 
Peak rejection level: 0 
D a r r û T n i ^ i »-. -* 4- *•*. •»-
D-7000 HSM: Olaquindox 
n-
Series: 0229 
Sample Name: 175352 
Analyzed: 10.01.02 11:58 Reported: 15.01.02 10:20 
Processed: 15.01.02 10:19 
Data Path: C:\Win32App\HSM\OLAQU\DATA\0229\ 
Application: Olaquindox Series:0229 
Injection from this vial: 1 of 1 Vial Number: 4 
Volume: 20,0 ul 
Sample Description: 
Chrom Type: Fixed WL Chromatoyram, 380 nm 
% 
Retention Time (min) 
Acquisition Method: Olaquindox 
Column Type: RP 18 
Pump A Type: L-7100 
Solvent A: MeOH/H20 
Solvent C: MeOH/H20 
Peak Quantitation: AREA 
Calculation Method: EXT-STD 
Name RT Area 
Solvent B: MeOH/H20 
Solvent D: MeOH/H20 
Sample Amount: 0,200 
Scale Factor 1: 1,000 
Cone 1 
Olaqu 
6,19 
6,88 
0 
29814 
0,000 
9,967 
29814 9,967 
Peak rejection level: 0 
BC 
MC 
Page Indicator 2 / 2 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 10-12-20011 
Analyte: 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
185350 
185353 
185368 
185395 
Result 1 
(mg/kg) 
2,10 
2.10 
8,60 
9,40 
Result 2 
(mg/kg) 
1,90 
2,50 
8,50 
9,60 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: ... 
Contact person: v. 
Date(s) of analysis: rAo..J.À.LL..^>.9.\.. 
Chromatographie rnnrtitinnv 
• Column:
 0 . 
As described in the method S i > * » l S « A ObS£ ; " È F ° **», £*»**• j % * * -
• ^Other : 
• Mobile phase: 
• ^ As described in the method 
• D Other: 
• Flow-rate: ..«<4r. m|/min 
• Injection volume: ..5fû...ul 
• Retention time of olaquindox: x>fk. min 
ChtOmatograms; Pteasn include reore ^ tentative chromatQgrams of: 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
fieciîSffiriLcesults: 
• Percentage recovery: At.. % 
• Single/duplicate determinations: o single ^duplicate 
• If duplicate, please give both percentages: .&£. % and .3X. % 
" Spiking level: ..&&... mg/kg 
Ui. WX1J.IU<->W J U . v^ v-»*.-.. 
Current Chromatogram(s) 
DAD1 A, Sig=380,4Ref=550,100(AD011210\CANFAS22.D) 
DAD1 A, Sig=380,4 Ref=550,100 (AD011210\CANFAS23.D) 
mAU 
1 4 -
1 2 -
10 
6 -
Blanc N' 185823 
2.5 mg/Kg 
10 12 14 min 
t of window 38: Current Chromatogram(s) 
/<? 
Current Chromatogram(s) 
DAD1 A, Sig=380,4 Ref=550,100(AD011210\CANFAS28.D) 
mAU 
1 4 ^ 
12 
10 
6H 
4H 
CM 
N*185360 10g/50ml 
— r — ' — ' — ' — r 
6 8_ 
-
1
 ' r~ 
10 
T i i i 1 , 
J 2 14 mir 
•> i i -
r- . i ^ . ft o 1 ~ - C 1 
t or winüow JÖ: current unr oma to gr aim s; 
Current Chromatogram(s) 
DAD1 A, Sig=380,4Ref=550,100(AD011210\CANFAS32.D) 
mAU 
14-
12 
10 
N' 185368 10 g/50 ml 
10 12 14 min 
't of window 39: Target + Library Spect rum /J7 
Target + Library Spectrum 
*DAD1, 8.359 (1.4mAU, - ) Ref=8.145& 9.185of CANFAS28.D 
'Olaquindox 
Anorm 
0.8 A 
0.6 -\ 
0.4-
0.2-
N'18535010 g/50 ml 
Olaquindox standard 1.25 pg/ml 
match = 858.7 
OH 
260 280 300 320 340 360 380 nml 
1 ' i ^ / r> i i r . A / r . n r i r>-.,»„ 1 „ ^ -, 
t of window 39: Target + Library spectrum 
Target + Library Spectrum 
*DAD1, 8.465 (9.3 mAU, - ) Ref=7.965 & 9.239of CANFAS32.D 
'Olaquindox 
Anorm 
3 -
0 -
N' 185368 10g/50ml 
Olaquindox standard 1.25 ug/ml 
match = 966 
260 280 300 320 340 360 
— I 
380 rwT 
/ 1 o / /> -I 1 / - . - Ï 1 . 0 0 *_ _ v . 
r>-a/-r^ 1 ^ - f 1 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
j Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |24/11-04/12/2001 
Analyte: 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
205367 
205377 
205417 
205428 
Result 1 
(mg/kg) 
9.09 
2,31 
9,00 
2,44 
Result 2 
(mg/kg) 
9.10 
2,33 
8,99 
2,38 
23 
CANFAS COLLABORATIVE STUDIES NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory:. 
Contact person: 
Date of analysis: december 2001 
Chromatographic conditions: 
• Column: 
• D As described in the method 
• • Other: ODS Hypersyl C18 200x4.6 mm, 5 um 
• Mobile phase: 
• J As described in the method 
• DOther 
• Flow rate: 1.5 ml/min 
• Injection volume: 100 ul 
• Retention time of nicarbazin: 6.8 min 
£ll£pmatofTrflnis; Please include representative chromatograms of: 
Blind positive feed sample 
Blind blank feed sample 
Bgcoyery results-
* Percentage recovery: 87.7% 
* Duplicate determination: 87.8% and 87.6% 
* Spiking level: 2.5 mg/Kg 
c* 
mAU 
17.5-
15-
12.5-
10 
7.5 
5-
2.5-
"• r 
1 
blonfc 
- i 1 ; 1 . 1 1 1 -
2 3 
- i — | — . — i — , — . — r 
6 7 -, . , r-8 
External Standard Report 
External Standard Report 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 23-11-2007] 
Je-mail: 
fax: 
telephone: 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
215341 
215351 
215401 
215422 
Result 1 
(mg/kg) 
3,40 
9,97 
3,35 
9,80 
Result 2 
(mg/kg) 
3,43 
9,41 
3,48 
9,16 
-2\ 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: . . . ! .* .„ .„ " * ~ ^ A ' 
Contact person:, ir.;.... 
Date(s) of analysis: ..JÀ Ài±..Ak\AÀ\l^?.ir. 
^OmaJORraohir. r.nnH\rim-
• Column: 
• D As described in the method 
• pother. §&fcX.Qjz^L...L<Z..Â2 :5.%.^.*kL^..±S#?^G?M&%b 
'
 Mobl|e Phase: ^ ' * ¥ ' 2 C u . , ^ ( K 
• ü As described in the method 
• KOmer: . £ . £ Ä . ^ - ACcîAVo L.^^P 
Hovwate: ...A,.4..... ml/min 3 o d n kW* ^ £ ) 
• Injection volume: ...SÇL.ul ' 
Retention time of olaquindox: %bS min 
^^^^Patagrams; Please include representative chromatog rams of: 
Blind positive feed samples 
B
'ind blank feed sample (from your own collection and to be used for recovery purposes) 
ease indicate the olaquindox peak with an arrow 
fifi£ûyerjafisutts. 
Percentage recovery:$3.,2% 
Single / duplicate determinations: o single ^duplicate 
lf duPlicate, please give both percentages:^.. % and 4<P$ % 
• Spiking level: .3,.5... mgAg 
S a t a F i l e Sample Nairn 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
22/11/2001 14.27.01 
5422-A 
22/11/2001 13.39.28 
C:\HI 
23/11/2001 9 .43.43 
(modified a f t e r loading) 
Seq. Line 
Locat ion 
In j 
In j Volume 
3 
V i a l 2 
1 
50 p i 
DAD1 A, Sig=365,8 Ref=off 
mAU -
^AQ,u\H&o>< 
E x t e r n a l Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
23/11/2001 9.43.38 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=365,8 Ref=off 
RetTime Type 
[min] 
Area Amt/Area Amount Grp 
[mAU*s] [ng inj.] Name 
7.659 MM 215.14258 4.55740e-l 98.04917 OLAQ-olaquindox 
Totals : 98.04917 
Results obtained with enhanced integrator! 
Sample Name; 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
DAD1 A, Sig=365,8 Ref=off 
22/11/2001 16.48.06 
22/11/2001 13.39.28 
23/11/2001 10.38.09 
(modified after loadinqj 
Seq. Line : 9 
Location : Vial 7 
Inj : 1 
Inj Volume : 50 ul 
2/ 
mAU J 
i 20 
OLftQaiV^^oK 
External Standard Report 
s
°rted By 
Calib. Data Modified 
^Itipuer 
Elution 
Signal 
23/11/2001 9.43.38 
1.0000 
1.0000 
Si 1gnal l;
 D A D 1 A / sig=365,8 Ref=off 
RetT 
tmin 
ime Type Area Amt/Area Amount Grp 
[mAU*s] [ng inj.] 
1 1__|. 
Name 
| I | I
7
-643 MM 56.26999 4.47699e-l 25.19200 OLAQ-olaquindox 
Totals : 25.19200 
^Results obtained with enhanced integrator! 
Da Sample Name: 
2/ 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
22/11/2001 16.24.33 
}
 6>LP\H!cFeöb 
Seq. Line : 8 
Location : Vial 6 
Inj : 1 
Inj Volume : 50 pi 
TTrjr'TiTTT* 
22/11/2001 13.39.28 
C-
23/11/2001 10 .38 .09 
(modified a f t e r loading) 
DAD1 A, Sig=365,8 Ref=off i 
m A U -
External Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
23/11/2001 9.43.38 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=365,8 Ref=off 
RetTime Type 
[min] 
Area Amt/Area Amount Grp 
[mAU*s] [ng inj.] 
I-
Name 
7.652 
Totals : 0.00000 
OLAQ-olaquindox 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
Warning : Calibrated compound(s) not found 
Diode Array 23/11/2001 10.40.08 Page 1 of 2 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX2-Reportform 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |01/11/15 01/ÏÎ/2Q 
Analyte: 
Je-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
225361 
225373 
225424 
555416 
Result 1 
(mg/kg) 
9,98 
2,45 
9,80 
2,60 
Result 2 
(mg/kg) 
9,73 
2,55 
9,88 
2,63 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory:. 
Contact person: 
Date(s) of analysis: ß!.iLl5"....|...P1.\)M.. 
Sfacamatogranhic conditions: 
• Column: 
• G As described in the method 
• Ga Other: ^fM&L&AJL.?.fià.&Aà ^ . ^ . ^ . ^ A f e . « ! * 
• Mobile phase: 
• JSCAs described in the method 
• G Other: • 
• Rowrate: ...J..v3>. ml/min 
• Injection volume: ..$$....pi 
• Retention time of olaquindox: .0..... min 
Qttamalpgrams: Ptease include representative chromatograms of: 
Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
pfease indicate the olaquindox peak with an arrow 
Percentage recovery: Ifi.L % 
Single / duplicate determinations: 0 single ft duplicate 
,f
 duplicate, please give both percentages: W?£ % and .f)3r % 
Spiking level: ?A?A>mg/kg 
NEW TIMED EVENTS FROM BAYONOX 
******* EXTERNAL STANDARD TABLE ******* 
******************** 11-17-2001 09:23:27 Version 5.1 ******************** 
* Sample Name : blank Data File: D:bayo07 
* Date: 11-11-2001 13 :29 :09Method: BAYONOX 11-17-2001 08:50:10 # 287 
* Interface: 0 Cycle#: 1 Operator ann Channel#: 0 Vial#: 
* Starting Peak Width: 2 Threshold: 1 Area Threshold: 100 
*************************************************************************! 
Starting Delay: 0.00 Ending retention time: 12.00 
Area reject: 1000 One sample per 0.200 sec. 
Amount injected: 50.00 Dilution factor: 1.00 
Sample Weight: 1.00000 
PEAK RET PEAK CONCENTRATION in NORMALIZED 
NUM TIME NAME ug/ml CONC 
AREA/ 
HEIGHT HEIGHT BL 
REP 
PEAK 
% DELTA 
RET TIME CONC/; 
TOTAL AMOUNT 
• PEAKS NOT FOUND IN THIS RUN 
NAME ADJUSTED RET.TIME. 
cAa 7.89 
REFERENCE PEAK 
ola 
Data File = D:bayo07.PTS Printed on 11-17-2001 at 09:23:31 
Start time: 0.00 min. Stop time: 15.00 min. Offset: 0 mv. 
Low Value: 0 uv High Value: 222486 uv Scale factor: 8.0 
22 
******* EXTERNAL STANDARD TABLE ******* 
r
*^***x************* 11-17-2001 09 : 25 : 43 -Version 5.1 ********************** 
Sample Name : prov nr 2 Data File: D:BAYO0 2 3 
;' Date: 11-16-2001 13 : 21 : 20Method: D : BAYONOX 11-17-2001 03:25:41 # 232* 
Incerface.- 0 Cycle#: 1 Operator ann Channel#: 0 Vial#: ^ * 
Starting Peak Width: 15 Threshold: 1 Area Threshold: 200 * 
*****************************************************************
 + lt. + .]tA. + + + ^  
'tarting Delay: 0.00 Ending retention time: 15.00 
'
rea
 reject: 200 One sample per' 0.200 sec. 
amount injected: 50.00 Dilution factor: 1.00 
;ample Weight: 1.00000 
:AK 
TOM 
' 
RET 
TIME 
8.151 
PEAK CONCENTRATION in 
NAME ug/ml 
ola 0.5100 
TOTAL AMOUNT - 0.5100 
NORMALIZED 
CONC 
100.0000% 
AREA 
33455 
AREA/ 
HEIGHT HEIGHT BL 
2147 15.6 1 
REF 
PEAK 
1 . 
% DELTA 
RET TIME 
0 
CONC/AREA 
1.5244E-U5 
*W3/ times, and heights stored in: D:BAYO028 .ATB 
ata File = D:BAYO028.PTS Printed on 11-17-2001 at 09:25:50 
tart time: 0.00 min. Stop time: 15.00 min. ' Offset: 
0 w
 Value: 0 uv High Value: 99159 uv Scale factor: 
« 
A. 
0 mv, 
8.0 
Souple ZZ5W*) 
******* EXTERNAL STANDARD TABLE ******* 
******************* 11-17-2001 OS : 26 :43 Version 5.1 ******************** 
Sample Name: prov nr'4 Data File: D:BAYO03 0 
Date: 11-16-2001 13 : 48 :HMethod: D:BAYONOX 11-17-2001• 09 : 25 : 41 # 25 
Interface: 0 Cycle#: 1 Operator ann Channel#: 0 Vial#: 
Starting Peak Width: 15 Threshold: 1 Area Threshold: 200 
************************************************************************ 
carting Delay. 0.00 Ending retention time: 15.00 
rea reject: 200 One sample per/ 0.20 0 sec. 
Tiount injected: 50.00' Dilution factor: 1.00 
ample Weight: 1.00000 
*K 
JM 
I 
RET 
TIME 
8.131 
PEAK CONCENTRATION in 
NAME ug/ml 
ola 1.97S4 
TOTAL AMOUNT - 1.9754 
NORMALIZED 
CONC 
100.0000Ï 
AREA 
129585 
AREA/ 
HEIGHT HEIGHT BL 
8302 15.6 1 
REF 
PEAK 
1 
% DELTA 
RET TIME 
0 
CONC/ 
1.524 
:<©;, times, and heights stored in: D : BAYOO-3 0 . ATB 
ita File = D:BAYO030.PTS Printed on 11-17-2001 at 09:26:46 
:art time: 0.00 min. Stop time: 15.00 min. Offset: 
)w Value: 0 uv High Value: 89418 uv Scale factor: 
0 mv. 
8 . 0 
Sample 2ZSkZM 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
j Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 15-12-20011 
Analyte: | 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
235325 
235310 
235342 
235365 
Result 1 
(mg/kg) 
2,35 
2,43 
8,55 
9,34 
Result 2 
(mg/kg) 
2,46 
2,30 
8,60 
9,50 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2-Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |12 dec 2001 | 
Analyte: | 
Je-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
245307 
245326 
245410 
245426 
Result 1 
(mg/kg) 
8,89 
2,10 
2,09 
8,40 
Result 2 
(mg/kg) 
7,99 
2,01 
2,01 
8,69 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2 0 0 1 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: - , ,. 
Contact person: 
Datefc) of analysis: ^....h^.T^....?^±. 
******** 
• Column: 
• 0 As described in the method 
• pother: ...<&*....+S/r.tt...t...J&..&..f.&. 
• Mobile phase: 
• yEJps described in the method , 
• O Olli«; 
• Rowwate: ....dt.tf..... mymin 
• Injection volume:..3".£. ...Ml 
Retention time of olaquindox: ..t.7... min 
flttamatpgran«- p)o a Bp »n^iiiriP rpnr^sffntative ctnamatograniB of; 
U/A. T+*rj_ -V 7ë. 
1
 positiva feed samples 
' yind blanK feed sample (from yuur own collection and to be used for recovery purposes) 
V*4e indicate the olaquindox peak with an arrow 
percentage recovery: % 
Single / duplicate determinations: D single X d u P | i c a t e 
N duplicate, please give both percentages: <£.?- % a" d % 
Spiking level:..?.,.*:. mg/kg 
RING-TEST CANFAS OLAQÜINDOX 
~ple u, 2.ejS~$c)?* 
13-12-01 17142 P.04 
0f 
Injection Date 
Sample Name 
Acq- OpezdLur 
Last changed 
12/12/01 16.56.48 
12/12/01 15.23.45 by ] 
(modified after loading) 
h Am A. ,sig=:wi,4 «itiSSO.lOO (CAOL2CX)1>.OLA12N33.0> 
mAU 
35 
30-
25-
20 
IS' 
10 
s 
w 88 g 
! Wi JilVW-
Location : Vial 1 
- i — — • — • — r 
Jfl 12 J5_ 
- 'T -
IS 
Externa l Standard Report ZA 
Sorted By s 
Calib. Data Modified s 
Mulllpiiei : 
nilntSon r 
Signal 
12/12/01 13.11.35 
1.0000 
1.0000 
Signal 1: DADl A, Sig=380,4 Ref-550,100 
R^tTimi» Typ« 
[min] 
A » a Amt /Arc* Amount Grp Nam« 
lmAU*s] (ng/ulj 
I 1 1 __ | 
9.870 PB 177,15262 1.00387e-2 1.77830 
Totals : 1.77838 
Results obtained with enhanced integrator I 
*** End of Report *** 
• I — I -
olaqumaox 
Instrument 1 12/12/01 17.12.48 Page 1 of 1 
'O 
P-INC-TEST CANFAS OT.AQUINDOX 
13-12-01 17142 P.85 
• M M « r - -
I n j e c t i o n Dace : I J S / 1 2 / O I 1 2 . 0 0 . 2 9 
3,äunpl«»JH41i\c L o c a t i o n : V i a l 1 
Acq. Operator 
Acq. Method 
L a s t changed 
: C : XHPCHEMUSMETHODSXCANfOA. .M 
: 1 2 / 1 2 / 0 1 1 2 . 5 9 . 4 7 t 
(modif<«d a f t e r l a a d i n q ) 
A n a l y s i s Method : Cs\HPCHEM\l\METHODS\ 
L a s t changed s 1 2 / 1 2 / 0 1 1 3 . L I . 2 4 b 
f m o d l f l e d a f t e r l o a d i n a ) 
0Ä0I A. Si8»3S0.4 Ref-SïÖ.KO <CA01200VOW12N'.Q.3> 
mAUl g $ 
35-
30-) 
25 
20 
15 
ia -
s -
-
0 -
I • 
S IC 
f l PS 
.' : i : /,-?3 «« 
1 ! C^ ^ C' « ao e - . 
*"-< 
IJ-' 
"T — J
-
10. JSL J4_ Jffi-
* * » » > 6 = X 
Sorted By 
5afib. Data Modiried 
Elution 
Signal 
12/12/01 12.59.44 
l.oooo 
1.0000 
Signal 1: DAUi A, Slg-300,4 R*£-S50,100 
Amt/Area Amount Grp Name 
[mRu's] l n g /^l„,-| 
I 1 > _ olaquindox 
*
cTime Type Area 
9.091 
totals 
I-
U.OÙOD0 
Résulta ©btûinod with .nhanr.r>H Integrator 1 
Warnings or Errors : 
Urning
 : calibrated cua^oundCa) not found 
'
tr
^ent 1 12/12/01 13.H.2Ï 
Pag« 1 of 2 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
J e-mail: 
fax: 
telephone: 
Date of analysis: |06 dec 01 | 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
255349 
255306 
255383 
255411 
Result 1 
(mg/kg) 
2,88 
10,25 
2,88 
10,50 
Result 2 
(mg/kg) 
2,86 
10,33 
3,02 
10,56 
14/12/01,
 1 0 : 5 7 N U ^ p 0 1 
2 f' 
CANFAS COLLABORATIVE STUDIES - 2nd ro/ind - NOVEMBER ^ OOX 
ADDmVE:OLAQUINpO> 
ibmex 4- - Questionnaire 
l^boratoryri..!.j|äi 
Contact person: ;:'.si 
,/.• v,-.' • ..'*,. 
• • /• •. .;••?'•!. 
• • • f » » » * • • • < P?tsf^ j>f ana^si$: .^..':r. * . ~ . ^2TZ 
• fihrgmafograohfe eanétiane: 
• Column: ' ( 
• o As described in the method , . .* \ 1 
. mother: £.?..£.'.* ^^^^.^..J!k9.r±...}^l^.)..M!^ê^ 
' Mobtie phase: 
. '.• 1 
• DAsdesaibedin-theunethocr - -,, ,« / 1 , . , • • , • 
•, Flowrate: .«k.J..... ml/W" 
• Injection volume: ...£?.....ui 
• Retention time of olaquindcKï ..$,£.. m&r / 
Cnrom^v.-^y p^f f l MMhte rr nr^nniatiw rhrnmatoirraim efc - . „ . . . . 
• Blind positive feed samples t 
- Blind blank feed s W »«n I « ^ co, ,ect ion and f * ÜSed for ^ ^ PUrP0SeS' 
fitoaseindcata ffw olaquMoxpeakwith an arrow \ j 
Bficnvprv results; 
• Percentage recovery: ««?.. % 
• Single/duplicetÇ determinations: D single »duplicate 1 
• )f duplicate, please give both percentages:»,??. * and fl.# * i 
• ' Spiking level: ..^£... mgAg • 1 ' ' j 
•/4 
14/12/01 10:57 NUM472 W 
6 > 
•rr-ç-••:•!; 
?Mrt I . " ••»/«•;'-
380 
•J.JttO /•5.C«: 
f, M l 
.i.:i> Lij 
jsrt-'irziSi« 
+4» 
'.•-üxrL.MLg.-.trj-w-* 
_ - .Ti - 'J -
- t r a ? 
MS^C 
v<* 
'BI 10:57 Mjrwf 
V;Ü;.- : W I UV REP T^E SmCTOS1/ 
'5CTÏM ÖATA T : : W K •-. : '. Or ia |C:iiO»3:*ftJ^:jl 
25 
»«PIE TASLf nc-f 
SVST2R ij s y s r a : 
•*' ;V 
Cfcirt Sptrt i.M' :*.;si;i 
380 I 
3,faV? 
j 
,VO*üo 1 O.OWO 
-.iïf JJ>-~ 
f f r.47 
i,?ï 
, . „ . . « s « * " -V-U 2.Wi 
2.34 
J . i i 
4 
A . 
4/ 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 19-H-26ÖÏ] 
e-mail: 
fax: 
telephone: 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
265390 
265398 
265404 
265413 
Result 1 
(mg/kg) 
7,32 
7,77 
2,20 
2,25 
Result 2 
(mg/kg) 
7,76 
7,85 
2,19 
2,25 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: 
Contact person:...: 
Date(s) of analysis : JjJl\J.?..9°l. 
Chromatographic conditions: 
• Column: 
• o As described in the method ^ 
.
 D otf,^ . 5^^A^.^.....Ç.:^.^...?......^^. ?.:£?.* ..£fr.£^. 
• Mobile phase: 
• cAs described in the method 
• D Other: 
• Row-rate: .../:.£?. m(/min 
• Injection volume: ./<Q...ul 
• Retention time of olaquindox: ..!*... min X&z, C e n - ^ ^ t y 
O V/Ds/ @ "SfC 
Chromatograms- Pliage 'ml\lti* representative chromatoerams oft 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
tovery results: _ 
• Percentage recovery: 7?.....% 
• Single / duplicate determinations: ».single o duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: .?.:.:?... mg/kg 
Software Version: 4.1<2F12> 
Date: 20/11/01 16:24 
Sample Name 
Data File 
Sequence File 
Instrument 
Sample Amount 
B3014229B 
C:\TC4\CANFAS\OLAQUI~1\REPEAT~1\DATA024.RAW 
C:\TC4\CANFAS\OLAQUI~l\REPEAT~l\RPTTRIAL.SEQ 
BOX_0 Rack/Vial: 0/0 Operator: 
: 1.0000 Dilution Factor : 
2' 6 
Date: 19/11/01 23: 
Cycle: 24 Channe 
1.00 
en 
I 
Q. l 
o t f l ö - ^ 
B ^ ' 
0 2 
• I I | I • ' 
4 6 
l | M I I | l l 
8 10 
Time [min] 
TT M I | l l l l | l l l l | ! I M | M ! l | l l l l | I I M | l l 
12 14 16 18 
Peak Time Area 
# [min] [uV-s] 
DEFAULT REPORT 
Height Area Norm. Area BL Area/Height 
[uV] [%] [%] [s] 
™ 9.018 203243.24 9421.37 100.00 100.00 *BB 21.57 
0 9.862 0.00 0.00 0.00 0.00 
203243.24 9421.37 100.00 100.00 
Missing Component Report 
Component Expected Retent ion (Cal ibra t ion Fi le) 
Olaquindox 9.862 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
j Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |21_11_01 | 
J e-mail: 
fax: 
telephone: 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
295319 
295354 
295356 
295418 
Result 1 
(mg/kg) 
6,49 
1,66 
1,90 
5,70 
Result 2 
(mg/kg) 
6,53 
1,61 
1,86 
5,97 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: *..... 
Contact person: 
Date(s) of analysis: GL.4.:.....i.(.:.:£>*l> 
Chromatographic conditions; 
• Column: 
• a As described in the method 
. tfOther: Mafa.-.fab. &.\* %/"* & .£XMß.ß??. .« f t> 
• Mobile phase: 
• TKf As described in the method 
• a Other: 
• Flow-rate: itSi m(/min 
• Injection volume: ../xaft.ul 
• Retention time of olaquindox: ^J.. min 
gbromatngramc- P I M < * i n c i u d e j ^ f r r n t n t i v e chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
• Percentage recovery: % 
• Single / duplicate determinations: D single ^duplicate 
• f duplicate, please give both percentages: \?X % and .'..<?... % 
• Spiking level: . .&.,£.. mg/kg 
Olaquindox Report 
Reported by User System Project Name: Olaquindox 
Sample Name-
Sample Type: 
Vial: 
Injection #: 
Injection Volume: 
RunTime: 
Spiked blank II 2.5 mq/ka 
Unknown 
35 
2 
100,00 i i 
15,0 Minutes 
Sample Set Name: OLAQUINDOX Nov 2001 
Acquired By: System 
Date Acquired: 21-11-20012204:34 
Acq. Method Set Olaquindox 
Date Processed: 22-11-2001 10:49:10 
Processing Method: > 
Proc. Chnl. Descr.: PDA 380,0 nm 
3 
< 
1 
Narre 
daq 
RT 
7,217 
Area 
91906 
Height 
6464 
Amount 
0,521 
l . 
Units 
Uug/rrt 
Printed 10:55:25 05-12-2001 Page: 1 of1 
Reported by User System 
<? 
Ï Olaquindox Report ? 
Project Name: Olaquindox 
Sample Name 
Sample Type: Unknown 
vial: 26 
Nection #•. 1 
•lection Volume: 100,00 U 
gnTime: 10,0 Minutes 
s^P le Set Name: olaquindox 22_01 
Acquired By: 
Date Acquired: 
Acq. Method Set 
Date Processed: 
Processing Method: 
System 
22-11-2001 1533:52 
Olaquindox 
23-11-2001 11:55:47 
Proc. Chnl. Descr.: PDA 380,0 nm 
1,00 2,00 
- i — i — i — i — i — i — r _ 
3,00 4,00 
1
 I ' "" 
5.00 
Mnutes 
1
 I ' ' 
6.00 
T—|—i—i—r 
7.00 8.00 9,00 10,00 
Name RT Area 
olaq 7.331 275380 
Height Amount 
13954 1,140 
Units 
Uug/rrt 
Printed 10:54:40 05-12-2001 Page: 1 of 1 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 27-11-2ÓÖT 
J e-mail: 
fax: 
telephone: 
Analyte: | OLAQUINDOX | 
Unit 
Sample code 
315359 
315399 
315414 
315429 
Result 1 
(mg/kg) 
8,71 
9,47 
2,70 
2,37 
Result 2 
(mg/kg) 
9,09 
9,40 
3,10 
2,57 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory:.. 
Contact person:.... 
Date{s) of analysis: ....2^..:.M.7..Q.\ 
StofifflatQgranhic conditions; 
• Column: 
• ös As described in the method 
• D Other: 
• Mobile phase: 
• Ä As described in the method 
• o Other: • 
• Flovwate: 1,5..... ml/min 
• Injection volume: ..U?Ü...ul 
• Retention time of olaquindox: .f. jËjirrün 
Qttamatograms.- piMiifl include reoreseiEältoSLäiwtäwmi ot 
Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Hsase indicate the olaquindox peak with an arrow 
Percentage recovery: 8.$fa 
Single / duplicate determinations: 0 single S duplicate 
,f
 duplicate, please give both percentages:& % and CjQr}% 
sPiWng level: .:?.,.£.. mg/kg 
Software Version 
Sample Name 
Instalment Name 
Rack/Vial 
Sample Amount 
Cycle 
6.1.2.0.1:D19 
HPLC-5 
0/0 
1,000000 
6 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
13-12-01 9:35:33 
27-11-01 16:40:05 
A 
1,000000 
r<ayw i 
£/ 
Result File 
Sequence Fi 
E 
c 
» 
Cd 
ttanK 
5,0 
Time [min] 
olaquindox 
Peak Component Time Area Height Area Norm. Area BL Area/Height 
# Name [min] [uV-s] [uV] [%] [%] [s] 
olaquindox 7,185 0,00 0,00 
0,00 0,00 0,00 0,00 
Missing Component Report 
Component Expected Retention (Calibration File) 
olaquindox 7,185 
Software Version 
Sample Name 
">strument Name 
Rack/Vial 
Sample Amount 
Cycle 
Ç o t ^ 
6.1.2.0.1:D19 
004273-a ^»Ç"555 
HPLC-5 
0/0 
1,000000 
9 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
13-12-01 9:36:20 
27-11-01 17:45:02 
A 
1,000000 
Page 1 of 1 
il 
5,0 
Time [min] 
olaquindox 
P e J * Component Time Area Height Area Norm. Area BL Area/Height 
* Nam« rmini riiv.nl fuVl [%] I%] ISJ e [ i ] [uVs] [ J 
" a i i i o [I I Ml I j IfJV OJ I M ' J » •» ' ' 
1
 olaquindox 7^01 124104,00 6005,22 ÏÖÖJÓÓ 100.00 B B 2 0 ' 6 6 6 0 
124104,00 6005,22 100,00 100,00 
Com'"9 Component Report 
• ~ ^ ° n e n t Expected Retention (Calibration File) 
^ p o r t e n t s were found 
Software Version 
Sample Name 
Instrument Name 
Rack/Vial 
Sample Amount 
Cycle 
: 6.1.2.0.1:D19 
: 004275-a 
: HPLC-5 
• 0/0 
1,000000 
16 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
13-12-01 9:37:42 
27-11-0120:16:38 
A 
1,0uuüuu 
raye 
3>\ 
f 
c 
8. 
V) 
<D 
CE 
5,0 
Time [min] 
Peak Component Time 
# Name [min] 
Area [uV-s] 
olaquindox 
Height Area Norm. Area BL Area/Height 
[MV] [%] [s] 
2 olaquindox 7,259 36148,25 1917,65 100,00 100,00 BB 18,8503 
36148,25 1917,65 100,00 
Missing Component Report 
Component Expected Retention (Calibration File) 
100,00 
All components were found 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
; Development and Validation of HPLC-methods for the official control of 
jCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 12-11-2001 j 
e-mail: 
fax: 
telephone: 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
325305 
325364 
325375 
325409 
Result 1 
(mg/kg) 
8,77 
3,16 
9,05 
3,14 
Result 2 
(mg/kg) 
8,37 
2,81 
9,05 
2,69 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: 12/11 /2001 
Chromatographic conditions: 
* Column: 
• Q As described in the method 
• # Other: LiChrospher ® RP-select B (5ym), 250 x 4 mm 
* Mobile phase: 
• #As described in the method 
• D Other 
* Row-rate: 1,8 ml/min 
* Injection volume: 70 Ou.) 
* Retention time of olaquindox: 4,14 min 
Sbfomatoorams- Ptamm inci»H» representative chromatoqrams of: 
•" S b S Ï Ï ' Î Ï Ï ^ ' S i m your own collection and to be used for recover purposes) 
Please indicate the olaquindox peak with an arrow 
Becpverv results-
* Percentage recovery: 83.3 % 
* Single/duplicate determinations: D single «duplicate 
' If duplicate, please give both percentages: 83.61% and 82.89% 
* Spiking level: 2.5 mg/Kg 
File C:\HPCHfcM\i\DAi AViznzuimuLAUuiui.u 
10.0023g 
O a i l l p l O I1CHIK3. WA.WWT 
42 
Injection Date : 11/12/01 2:29:51 PM Seq. Line : 1 
Sample Name : 325364 Vial: 1 
Acq. Operator Inj : 1 
Inj Volume : 70 ul 
Acq. Method : C:\HPCHEM\1\METHODS\OLAQUIN.M 
Last changed 
Analysis Method : C:\HPCHEM\1\METHODS\OLAQUIN.M 
Last changed c 
(modified after loading) 
DAD1 A, Sig=380,100 Ref=550,50 (12112001 \OLAQUI01 .D) 
ciacpuindo* 
(6 
S 
External Standard Report 
^Sorted By Signal 
Calib. Data Modified : 11/12/01 4:41:01 PM 
Multiplier 1.0000 
Dilution 1.0000 
Signal 1: DAD1 A, Sig=380,100 Ref=550,50 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ug/ml] 
1 1 1 1 1_, 
4.095 MM 30.92293 2.04513e-2 6.32414e-1 Olaquindox 
Totals: 6.32414e-1 
Results obtained with enhanced integrator! 
Pagdof 1 
i File C:\HPCHEM\1\DATA\12112001\OLAQUI07.U 
10.0029g 
sample Name: JZDJ/O 
Injection Date : 11/12/01 3:27:35 PM Seq. Une : 7 
Sample Name : 325375 Vial: 7 
Acq. Operator Inj : 1 
Inj Volume : 70 ul 
Acq. Method : C:\HPCHEM\1\METHODS\OLAQUIN.M 
Last changed 
Analysis Method : C:\HPCHPM\i\MFTHnns\OLAQUIN.M 
Last changed : - . 
(modified after loadinal 
*. 
DAD1 A, Sig=380,100 Ref=550,50 (12112001\OLAQUI07.D) 
External Standard Report =================== 
''iSortedBy Signal 
Calib. Data Modified : 11/12/01 4:41:01 PM 
Multiplier 1.0000 
Dilution 1.0000 
s
'9nal 1: DAD1 A, Sig=380,100 Ref=550,50 
RetTime Type Area Amt/Area Amount Grp Name 
f"1'"] [mAU*s] [ug/ml] 
4
-107~MM 90~84964 1.99336e-2 1.81096 Olaquindox 
T
°tals: 1.81096 
Results obtained with enhanced integrator! __=_===========:============= 
Pagelof 1 
r-File C:\HPCHEM\1\DATA\12112001\OLAQUI18.D bam pie Name: tiian« 3>2 
Injection Date : 11/12/01 4:57:15 PM Seq. Line : 18 
Sample Name : Blank Vial: 13 
Acq. Operator Inj : 1 
Inj Volume : 70 ul 
Acq. Method : C:\HPCHEM\1\METHODS\OLAQUIN.M 
Last changed 
(modified after loading) 
Analysis Method : C:\HP^HEM\1\METHODS\OLAQUIN.M 
Last changed : 1 \,A 
(modified after loadina) 
External Standard Report 
d" 
Sorted By Signal 
Calib. Data Modified : 11/12/01 4:41:01 PM 
Multiplier 1.0000 
Dilution 1.0000 
Signal 1 : DAD1 A, Sig=380,100 Ref=550,50 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ug/ml] 
-I 1- - l - l 
Olaquindox 4.139 
Totals : 0.00000 
Results obtained with enhanced integrator! 
Pagelof 2 
pite C:\HPCHEM\1\DATA\12112001\OLAQUI19.U sample Name: opiKeu i 
Ilnjection Date : 11/12/01 5:04:52 PM Seq. Une: 19 
iSample Name : Spiked 1 Vial: 14 
|Acq. Operator : i Inj : 1 
Inj Volume : 70 pi 
Acq. Method : C:\HPCHEM\1\METHODS\OLAQUIN.M 
Last changed : : 01 
(modified after loading) 
Analysis Method : C:\HPCHEM\1\METHODS\OLAQUIN.M 
I Last changed : 1 
(modified after loading) 
S2 
DAD1 A, Sig=380,100 Ref=550,50 (1211200UOLAQUI19.D) 
mAU i 
Spiked sample 
*f 
External Standard Report 
Sorted By ; Signal 
~
a
' 'b. Data Modified : 11/12/01 4:41:01 PM 
Multiplier 1.0000 
Dilution 1.0000 
S
'9nal 1: DAD1 A, Sig-380,100 Ref=550,50 
^etTime Type Area Amt/Area Amount Grp Name 
lm,n] [mAU*s] [ug/ml] 
4
-119MM 20.02315 2.08786e-2 4.18055e-1 Olaquindox 
Tota |s : 4.i8055e-1 
Results obtained with enhanced integrator! 
Pagelof 2 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
j Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Eeed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY - 2nd round 
e-mail: 
fax: 
telephone: 
11-7-2001 
OLAQUINDOX 
Unit 
Sample code 
335304 
335308 
335347 
335362 
Result 1 
(mg/kg) 
2,70 
9,10 
2,90 
8,90 
Result 2 
(mg/kg) 
2,60 
8,80 
2,70 
8,80 
35 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2 0 0 1 
ADDITIVE: OLAQUINDOX 
Annex 4 - Que 
Laboratory:.... 
Contact persor 
Date(s) of analysis: IJMJ.01.. 
Chromatographic conditions; 
• Column: 
• X ^ described in the method 
• D Other: 
• Mobile phase: 
• X Ä S described in the method 
• a Other: 
• Row-rate: ml/min 
• Injection volume: M' 
• Retention time of olaquindox: Aß... min 
Chrnmatn^msr Please include rm^m^J^mmSTSEOUit 
• Blind positive feed samples 
. Blind blank feed sample (from your own collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
fiecovery restas; 
• Percentage recovery: M>X. % 
• Single / duplicate determinations.'Xsing'e D duplicate 
• If duplicate, please give both percentages: % a"d 
• Spiking level: ..-£7.... mg/kg 
Sanple Set Name OLA07 
User Name RVSA 
Current Date 7/11/01 
Current Time 02:05:47 
280,00 
290.00 300,00 
Spectrum Index Plot 
OLA - 2,892 
nm 
310.00 320,00 330.00 340,00 350.00 360.00 370,00 380,00 390.00 
4,00 
1 
SampleName 
6361/01 
Name 
OLA 
Peak Results 
RT 
2,892 
Area 
88145 
Height 
9141 
Amount 
2.877 
Units 
mg/kg 
335-3H> 
Sanple Set Name OLA07 
User Name RVSA 
Current Date 7/11/01 
Current Time 02:05:45 
Spectrum Index Plot 
OLA - 2,898 
nm 
360.00 370,00 380.00 390,00 
4.00 
r-
1 
SampleName 
6360/01 
Name 
OLA 
Peak 
RT 
2.898 
Results 
Area 
284980 
Height I Amount 
32412 j 9,048 
Units 
mg/kg 
&s*oi 
Sanple Set Name OLA07 
User Name RVSA 
Current Date 7/11/01 
Current Time 02:05:38 
Spectrum Index Plot 
0,00 
0,10 0,20 0,30 0,40 
nm 
0.50 0,60 0,70 0,80 0,90 1,00 
-0,002-
4,00 
Peak Results 
1 
SampleName 
BLK 
Name 
OLA 
RT 
2,873 
Area Height Amount Units 
Sartple Set Name OLA07 
User Name RVSA 
Current Dote 7/11/01 
Current Time 02:05:39 
280,00 
Spectrum Index Plot 
OLA-2,923 
nm 
340,00 350,00 360,00 370,00 380.00 390,00 
^ o.oio^ 
0,50 1,00 
4,00 
Minutes 
Peak Results 
Height 
19958 
Amount 
5,114 
Units 
mg/kg 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
|Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY - 2nd round 
e-mail: 
fax: 
telephone: 
08-01-2002 
OLAQUINDOX 
Unit 
Sample code 
345321 
345366 
345379 
345386 
Result 1 
(mg/kg) 
8,60 
2,40 
8,80 
1,90 
Result 2 
(mg/kg) 
8,30 
2,20 
8,40 
1,90 
>v 
KromaSystem 2000 
Channel 2 
KromaSystem 2000 Version 1.83 RESULT REPORT: INTEGRATION 
SYS2 - OLAQ37.SMP (modified) 
No. 08: 345321 10g/50ml 
Channel 2: DETECT 332 
No Text 
«^ MLiiiea : 08.01.02 12:25:20 
Processed: 18.03.02 11:51 
Program File OLAQ001 
Worksheet OLAQ 
Peak Table OLAQOIND 
Parameter Table .. OLAQUIND 
Report File 
Document F i l e . . . . 
50.fr 
No. PNo Ret.Time Type 
min 
Name 
8.58 MOD olaquindox 
Area 
mV*min 
Amount Rel.Ar 
% 
4.4462e+000 8.5929e+000 100.00 
4.4462e+000 8.5929e+000 100.00 
Sample Report Page 
1 of 1 Printed: 21-03-02 9:21 
•:-V 
KromaSystem 2000 
Channel 2 
KromaSystem 2000 Version 1.83 RESULT REPORT: INTEGRATION 
SYS2 - OLAQ37.SMP (modified) 
No. 10: 345366 10g/50ml 
Channel 2: DETECT 332 
No Text 
Acquired : 08.01.02 12:51:31 
Processed: 18.03.02 11:51 
Program File OLAQ001 
Worksheet OLAQ 
Peak Table OLAQUIND 
Parameter Table .. OLAQUIND 
Report File 
Document File .... 
50.0-
37.5-
30.0-
22.5-
15.0-
No. PNo Ret.Time Type 
min 
Name 
8.4 9 MLR olaquindox 
Area 
mv*min 
Amount Rel.Ar 
% 
1.2242e+0002.3659e+000 100.00 
1.2242e+000 2.3659e+000 100.00 
Sample Report Page 1 of 1 
Printed: 21-03-02 9:22 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: 112/13-11/200?] 
Analyte: | 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
355317 
355322 
355357 
355406 
Result 1 
(mg/kg) 
2,00 
2,00 
7,90 
7,60 
Result 2 
(mg/kg) 
2,00 
2,00 
7,50 
7,70 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: , 
Contact person: 
Date(s) of analysis I i / i 3 - H - Zool 
Chromatographic conditions: 
• Column: 
• pS As described in the method 
• D Other: 
• Mobile phase: 
• ^ As described in the method 
• D Other: 
• Flow-rate: I r ^ ml/min 
• Injection volume: .;5Ç?....ul 
• Retention time of olaquindox: ^H min 
Chroma^grams; p|ft?«A include renrrïffntativft chromatograms of: 
• Blind positive feed samples 
• Blind b lank je jd jampJe-^^ collection and to be used for recovery purposes) 
Please indicate the olaquindox peak with an arrow 
Hfigoverv results-
• Percentage recovery: IQ^.1% 
• Single / duplicate determinations: 0 single ^duplicate 
• If duplicate, please give both percentages: të^ % and JCj f^ % 
• Spiking level: 3 . . i L . mgAg 
Olaquindox 
0.0050 -
0.0025 -
0.0000 -
•0.0025 -
\ "O 
\ c \ « "3 \ il « °" \ j \ « A <D 
W\ ƒ \ 5 
1 i 1 
~A./v , 
T 1 • r 1 
8 
Minute» 
10 12 
aak: Olaquindox - ESTD - UV-Detect 
f 
0 20000C00000 
Area 
0.0050 
0.0025 
0.0000 
•0.0025 
14 
UV-Detector 
Results 
pjc # Retention Time Area 
Olaquindox 1 7.20 31052 
Height 
1070 
ESTD Units 
concentration 
1.95262 mg/kg 
APPENDIX 5 
Table with results, questionnaire (page 1) and chromatograms 
of partner 37 
CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
I Development and Validation of HPLC-methods for the official control of 
jCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY - 2nd round 
e-mail: 
fax: 
telephone: 
11-12-2001 
OLAQUINDOX 
Unit 
Sample code 
375311 
375343 
375387 
375405 
Result 1 
(mg/kg) 
2,02 
7,54 
1,87 
8,34 
Result 2 
(mg/kg) 
1,92 
8,09 
1,88 
7,91 
IßlUI 
•37-
CANFAS COLLABORATIVE STUDIES - 2nd round • NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
t • +• 
Laboratory: **•• 
Contact person:.... 
Date(s) of analysis: . . . . «A I IA IS . ' . . 
Chromatographie conditions: 
• Column: 
• • As described in the method /"• 
• B-Qther. ....±A.M££$ZZe?->-'^ 
• Mobile phase: 
• trAs described in Uie method 
• D Other: 
• Flowate: ....A ml/min 
• Injection volume: ,.êP....ul 
• Retention time of olaquindox: AhS ruin 
Chromato^m^ P\»zse include représentai <?hrornafagram$ ofc 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for „cam, purposes) 
please indicate the olaquindox peak with an arrow 
fesaverv results; 
* Percentage recovery: !:...£ % 
• Single / duplicate determinations: D single replicate 
• If duplicate, please give both percentages: . O % and • • * * • % 
* Spiking level: .£:.§.... rngAB 
Olaqulndox In Feed 
Made: Reprocessed Data 
Original Results: C:\TSP\SYSTEMl\Daia\111201olaqps-RES 
Reprocessed Hesurts: CM SH\$Y!s' ChMI \uaraVT 11 üUl olaqps.HMb 
A n a l y s i s R e p a r t 
Name: 881b 
Description: 88 lb 
Type: Sample 
Injection Volume: 50.0 \iL 
Acquisition Log 
Column Pressure (PSI): 2992 
Noise (microAU): 6e*0i 
Run-TImo Messages: None 
ViaJ:Aiö 
Page 2fi 
Repnrtfid On-19-19-01 11 -nfl-.'W 
injection: 1 o' 1 
Injected On: 12-12-01 06:01:38 
Column Temperature (C): N/A 
Drift (mlcroAU/mln): -1er02 
Pump Raw Subiliiy. o.s 
Slanal 1 : UV2000 A 380 nm 
Calculation Type: External Standard (Height) 
mV or mAU 
m CD 
Aflffi -~*9R 
. . "îTBÛO 
M 
"27T5Ö 
37 
/ 
~-=~-11 .536 olaqulndox 
S 
!LK) 
-+* 
'J\ 
-F 
O 
"J> 
er 
te-
C 
S 
§ 
> 
CD 
O 
» • 
Olaquindox in Feed 
Mode; Reprocessed Data 
Original Recuite; C:\TSP\SYSTEM1 \Data\.111201 dappe-HES 
Reprocessed Results: C:\TSP\SYSTEMlU3ataMt1201olaqps.RMS 
Page 23 
Reported On: 12-12-01 11:09.-33 <37 
A n a l y s i s r i e p o r t 
Name: 879b 
Description: 079b 
Type: Sample 
Injection Volume: 50.0 uL 
Acquisition Log 
Column Pressure (PSI): 295B 
NoisB (microAU): 9e»01 
Run-Tim» Massages1 Non» 
Vial: A M Injection: 1 of 1 
Injormri On-19.13-01 03:25:00 
Column Temperature (CJ: N/A 
Drill (microAU/min): -2e+ui 
Pump Flow Stability: 1.1 
Signal 1: UV2000 A 380 nm 
Calculation Type: External Standard (Height) 
o 
O p-
mv or mAU 
€ L S 4 0 1.002 
Ü.111 
tti-
c 
ta 
.— -> 11.513 alsquindox 
— 8 
e 
Olaquindox in Peed 
Mode; Reprocessed Data 
Original neauto: C:VT5PNSYSTEM1VDataM11S01elaqps.neS 
Reprocessed Results: CATSP\SYSTEMl\Data\lll20lolaqps.RMS 
A n a l y i l » R e p o r t 
Name; bIK teed 
Dasuiutfun. Ulk (und 
Type: Sample 
Injection Volume: 50.0 uL 
Acquisition l.ng 
Column Pressure (PSI): 2806 
Noise (microAU): 3e*01 
Run.Timo Massages: Nana 
Vial:A08 
Page 17 
Reporter! On: 12-12-01 11:09:31 
Injection: 1 of 1 
InjenadOn: 12-12-01 00:17:07 
37 
Column Temperature (C): N/A 
Onrt (microAU/min): 2e+U2 
Pump Row Stability: 1.7 
Signal 1: UV2000 A 380 nm 
Calculation Type: External Standard (Haight) 
M 
^s-f i f inR 
mV or mAU 
OB M 
•1.151 
JLU2 
in 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
|Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY - 2nd round 
10-12-20011 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
385336 
385355 
385369 
385374 
Result 1 
(mg/kg) 
7,82 
2,30 
2,60 
7,50 
Result 2 
(mg/kg) 
6,86 
2,36 
2,22 
7,83 
CANFAS COLLABORATIVE STUDIES - OLAQUINDOX II 
Annex 4 - Questionnaire 
Laboratory: 
Contact Person: 
Date(s) of analysis: 12/10/01 
Chromatographic conditions: 
• Column: 
D As described in the method 
X Other: Symetry® C-18,150 x 2,1 mm, 3.5 um 
• Mobile phase: 
G As described in the method 
X Other: Isocratic MeOH/Water (5:95) 
• Flow-rate: 0.3 ml/min 
• Injection volume: 1 0 M' 
• Retention time of Carbadox: 12.9 min 
Chromatoarams: Please include representative chromatoqrams of: 
• Blind positive feed samples 
• Blind blank samples 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: 52.5 % 
• Single/duplicate determinations: D single X duplicate 
• If duplicate, please give both percentages: 52% and 53% 
• Speaking level: 2 mg/kg 
i8 
OLQXC012011 
10(H - 1 4 0 
% • 
;=*„ 
2: Diode Array 
375 
8.00e3 
'I ' ' ' ' i ' ' ' ' i ' ' ' • i ' ' " i ' " • i " ' • 1 • •• ' 1 • ' " i " •• i • • •• i • " • i ' " • i ' ' " i " • 
2.50 5.00 7.50 10.00 12.50 15.00 17.50 
> Time 
blonk 
0LQXC012012 
1 0 0 T 
18C4 
2: Diode Array 
375 
8.00e3 
Area, Height 
13.21 
910 
449 
1 1 1 I • • 1 1 I 1 • 1 1 I • 1 • 1 I •• •• I • • • • ! 1 • " I ' ' " I ' ' ' • I " " l " " T " " I " " I " " I ' 
2.50 5.00 7.50 10.00 12.50 15.00 17.50 
• Time 
spiked blank: ($ tony Ike) 
0LQXC012017 
100n 
%-
2. Diode Array 
375 
8.00e3 
Area, Height 
13.53 
1760 
2156 
ol T"'. i n'n'im i r 111 M " ' i I ' l i ' i ' i n p i i | i n i | 11.M Time 
2.50 5.00 7.50 10.00 12.50 15.00 17.50 
sionclo^d ohqunndoX 
0LQXC012001 
100n n 
% 
34 ^ 
2: Diode Array 
375 
8.00e3 
Area, Height 
12.95 
407 
504 
' I ' ' ' ' I ' " • I ' • I • ' • • I • • • • I • 
2.50 5.00 7.50 10.00 12.50 15.00 17.50 
11 • • 1 Time 
2,85bty/i 
0LQXC012006 
100n 
a 
2: Diode Array 
375 
8.0063 
Area, Height 
13.01 
1881 
1512 
" 'I • • 111 11 ' n | i ' • ' 11 ' n ' i • ' i ' 11111111 1 1 1 1 1 . 1 1 , i , 
2.50 5.00 7.50 10.00 12.50 15.00 17.50 
Time 
3#53>6/é 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
|Development and Validation of HPLC-methods for the official control of 
IÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: |26.11.-6.12.07] 
Analyte: 
J e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
405315 
405381 
405385 
405391 
Result 1 
(mg/kg) 
2,67 
8,84 
8,93 
2,87 
Result 2 
(mg/kg) 
2,82 
8,87 
8,96 
2,84 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory:., 
Contact person: 
Date(s) of analysis: Mf}°X$m!tfïr....'r. 6.d*<ït.K\h&r....fe.'?A. 
Chromatographic conditions: 
• Column: 
• G As described in the method . 
. j*0*er: ....^/. ^.tóftil $*.« M £ * £ ^ ± * ! . ! * £ . 
• Mobile phase: 
• JS As described in the method 
• D Other: 
• Flovwate: . . .<l f3. ml/min 
• Injection volume: ..5ß...ul 
• Retention time of olaquindox: .?/.£ min 
Chromatograms- PI«,««« inniude reorrTontatiw chromatograms ofc 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposes) 
^ease indicate the olaquindox peak with an arrow 
Hscoverv results-
• Pfcceolàge recovery:. !?.?.. % 
• Single / duplicate determinations: a single g duplicate 
• If duplicate, please give both percentages: 36..% and i f . . . % 
• Spiking level: ..<?/.£.. mgAg 
TIME DATE 
INJECTION 15:46:37 4 DEC 2001 
ANALYSIS 15:14:32 5 DEC 2001 
REPORT 16:13:03 6 DEC 2001 
0.0000 
Absorbance 
0.0100 
0.0100 
Absorbance 
0.0200 
0.0200 
CANFAS sample 405381 
TIME DATE 
INJECTION 15:37:01 4 DEC 2001 
ANALYSIS 12:28:34 5 DEC 2001 
REPORT 16:13:49 6 DEC 2001 
0.0000 
0.0000 
Absorbance 
0.0100 
J L 
0.0200 
0.0200 
Absorbance 
CANFAS sample 405315 
Blank piglet feed 
TIME DATE 
INJECTION 16:04:02 6 DEC 20 
ANALYSIS 16:13:21 6 DEC 20 
REPORT 16:16:36 6 DEC 20' 
1.0000 
Absorbance 
0.0100 
J I I L 
0.0200 
J I I I i 
5 
i r 
0.0000 
1 , J — 
0.0100 
Absorbance 
i i 1 r 
0.0200 
J 
m. 
TIME DATE 
INJECTION 16:26:34 4 DEC 2001 
ANALYSIS 12:23:25 5 DEC 2001 
REPORT 16:15:03 6 DEC 2001 
Absorbance 
0.0200 
0.0100 
Absorbance 
n , , 
0.0200 
Spiked blank for recovery test 1 
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CANFAS COLLABORATIVE STUDIES - 2ND ROUND - NOVEMBER 2001 
ANNEX 2 - Report form 
CANFAS 
|Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY - 2nd round 
Date of analysis: | 19-11-2ÓÖT 
e-mail: 
fax: 
telephone: 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
415320 
415330 
415396 
415430 
Result 1 
(mg/kg) 
2,67 
2,48 
9,85 
9,77 
Result 2 
(mg/kg) 
2,82 
2,60 
9,93 
9,98 
k 
CANFAS COLLABORATIVE STUDIES - 2nd round - NOVEMBER 2001 
ADDITIVE: OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: . . . . / £ { . . $ . . € < . . # £ / . 
Chromatographic conditions: 
• Column: 
• AAs described in the method 
• a Other: 
• Mobile phase: 
• X As described in the method 
• a Other: 
• Flow-rate: ...(.i.e. m|/min 
• Injection volume: ./.Q.Q..\A 
• Retention time of olaquindox: Ir.f.r.. min 
Chromatograms! Please include representative chromatograms oft 
• Blind positive feed samples 
• Blind blank feed sample (from your own collection and to be used for recovery purposed 
PleeseindicatetoeCacuindoxpe^anarro* * £ » / J % , ? ' ^ Z o s e ^ 
Recovery results? 
Percentage recovery:A?fi.<?% 
Single/duplicate determinations: D single X duplicate 
• If duplicate, please give both percentages/^% and?..«... % 
Spiking level: f£<.~... mg/kg 
• 
• 
Current Date 10.12.2001 
HI 
1 of 
Sample Information 
SampleName 
Vial 
Injection 
Injection Volume 
Channel 
Run Time 
4118 
9 
1 
100,00 ul 
486 
15,0 Minutes 
Sample Type 
Date Acquired 
Acq Method Set 
Processing Method 
Date Processed 
0,0030-
0,0025-
0,0020-
3 
< 
0,0015-
0,0010-
0.0005-
\ 
\ 
\ 
\ . 
Auto-Scaled Chromatogram 
4 
IT-- \ 
" i—i—i—i—|—I—i—i—i—|—i—i—I—i—|—r 
6,00 7,00 8,00 
~t—I—i—i—i—i—I—i—r 
~1 ' ' ' i I i i i—i—I—i—i—i—i—|—i—i—i—r-
9.00 10,00 11,00 12,00 13,00 14,00 15 00 
Mnutes 
Peak Results 
N 
1 
Name RT 
10,394 
Area 
72042 
Height 
2369 
Amount 
4773,406 
Units 
ug 
Current Date 10.12.2001 
11 
1 o 
SampteName 
Vial 
Injection 
Injection Volume 
Channel 
Run Time 
4119 
10 
2 
100,00 ul 
486 
15,0 Minutes 
o.ootH 
Sample Type 
Date Acquired 
Acq Method Set 
Processing Metric« 
Date Processed 
Auto-Scaled Chromatogram 
10,00 
Mnutes 
11,00 «.DO 
i — i — i — i — i — i — I ' ' ' S^H.00 15.00 
